Enediyne Conjugates | ADC Payloads | United States | 11547763 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | United States | 10953106 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | United States | 11833222 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | Singapore | 10202006863Y |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | Switzerland | 3878861 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | Spain | 3878861 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | Japan | 6932649 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | Japan | 7439024 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | United Kingdom | 3878861 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | Korea - South | 10-2672113 |
CL And/Or CH1 Mutated Antibodies For Drug Conjugation | ADC Technology | UPC Agreement | 3878861 |
Immunoglobulin Variants | AggreSolve™ Screening Technology | United States | 8951516 |
Immunoglobulin Variants | AggreSolve™ Screening Technology | United States | 9290563 |
Immunoglobulin Variants | AggreSolve™ Screening Technology | Japan | 5901522 |
Compositions, Methods, and Kits for Detection of Lipolytic Activity | Analytical Assays | Switzerland | 4028542 |
Compositions, Methods, and Kits for Detection of Lipolytic Activity | Analytical Assays | Spain | 4028542 |
Compositions, Methods, and Kits for Detection of Lipolytic Activity | Analytical Assays | Japan | 7675704 |
Compositions, Methods, and Kits for Detection of Lipolytic Activity | Analytical Assays | United Kingdom | 4028542 |
Compositions, Methods, and Kits for Detection of Lipolytic Activity | Analytical Assays | UPC Agreement | 4028542 |
Method For Preparation Of N-Carboxyanhydrides | API Manufacturing Methods | Germany | 3810579 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | API Manufacturing Methods | Germany | 3619188 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | API Manufacturing Methods | United States | 11001552 |
Method For Preparation Of Carsalam | API Manufacturing Methods | United States | 12304892 |
Method For Preparation Of Carsalam | API Manufacturing Methods | Australia | 2020277650 |
Method For Preparation Of Carsalam | API Manufacturing Methods | Mexico | 410628 |
Method For Preparation Of N-Carboxyanhydrides | API Manufacturing Methods | Switzerland | 3810579 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | API Manufacturing Methods | Switzerland | 3619188 |
Method For Preparation Of Carsalam | API Manufacturing Methods | Switzerland | 3972961 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | API Manufacturing Methods | China | ZL201880047848.6 |
Method For Preparation Of Alpha-Methyl-L-Proline | API Manufacturing Methods | China | ZL201880042883.9 |
Method For Preparation Of Carsalam | API Manufacturing Methods | Spain | 3972961 |
Method For Preparation Of Carsalam | API Manufacturing Methods | Israel | 287941 |
Method For Preparation Of Carsalam | API Manufacturing Methods | India | 537768 |
Method For Preparation Of N-Carboxyanhydrides | API Manufacturing Methods | Japan | 7042969 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | API Manufacturing Methods | Japan | 6737967 |
Method For Preparation Of Carsalam | API Manufacturing Methods | Japan | 7105386 |
Method For Preparation Of N-Carboxyanhydrides | API Manufacturing Methods | France | 3810579 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | API Manufacturing Methods | France | 3619188 |
Method For Preparation Of N-Carboxyanhydrides | API Manufacturing Methods | United Kingdom | 3810579 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | API Manufacturing Methods | United Kingdom | 3619188 |
Method For Preparation Of Carsalam | API Manufacturing Methods | United Kingdom | 3972961 |
Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester | API Manufacturing Methods | Hong Kong | HK40019698 |
Method For Preparation Of Alpha-Methyl-L-Proline | API Manufacturing Methods | Hong Kong | HK40017759 |
Method For Preparation Of Carsalam | API Manufacturing Methods | Korea - South | 10-2566591 |
Method For Preparation Of Carsalam | API Manufacturing Methods | UPC Agreement | 3972961 |
Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | Arabinogalactan Composition Use | United States | 9393259 |
Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | Arabinogalactan Composition Use | Australia | 2013231673 |
Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | Arabinogalactan Composition Use | Singapore | 10201707481S |
Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | Arabinogalactan Composition Use | Canada | 2907635 |
Composition Comprising Arabinogalactan and Polyphenols from Larch Trees | Arabinogalactan Composition Use | Japan | 6490662 |
Arabinogalactan for Enhancing the Adaptive Immune Response | Arabinogalactan Use | United States | 8784844 |
Pharmaceutical Compositions With Enhanced Performance | ASD Compositions | United States | 8940800 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | Germany | 2776016 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | Germany | 3167880 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | Germany | 2852412 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | United States | 9980918 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | United States | 11246837 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | Belgium | 2776016 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | Belgium | 3167880 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | Belgium | 2852412 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | Netherlands | 2776016 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | Netherlands | 2852412 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | Canada | 2873837 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | Spain | 2852412 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | Italy | 2776016 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | Italy | 2852412 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | Japan | 6598841 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | Japan | 6306573 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | Japan | 6836977 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | Japan | 6219836 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | Japan | 6768060 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | France | 2776016 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | France | 3167880 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | France | 2852412 |
Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | United Kingdom | 2776016 |
Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules | Capsule - Banding | United Kingdom | 3167880 |
Acid Resistant Banding Solution for Two Piece Hard Capsules | Capsule - Banding | United Kingdom | 2852412 |
Delivery Carrier | Capsule - Fill Formulations | Germany | 602010025605.7 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | Capsule - Fill Formulations | Germany | 3082778 |
Curcumin Solid Lipid Particles and Methods for their Preparation and Use | Capsule - Fill Formulations | Germany | 2964243 |
Liquid Filled Delivery System | Capsule - Fill Formulations | United States | 8795720 |
Delivery Carrier | Capsule - Fill Formulations | United States | 9333177 |
Hard Capsule Formulation | Capsule - Fill Formulations | United States | 10172803 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid | Capsule - Fill Formulations | United States | 10188611 |
Curcumin Solid Lipid Particles and Methods for their Preparation and Use | Capsule - Fill Formulations | United States | 10166187 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | Capsule - Fill Formulations | Belgium | 3082778 |
Curcumin Solid Lipid Particles and Methods for their Preparation and Use | Capsule - Fill Formulations | Belgium | 2964243 |
Hard Capsule Formulation | Capsule - Fill Formulations | Brazil | BR112015020307-8 |
Hard Capsule Formulation | Capsule - Fill Formulations | Japan | 6420261 |
Hard Capsule Formulation | Capsule - Fill Formulations | Japan | 6856601 |
Capsule Formulation Comprising Bifidobacterium Bacteria and the Production Method Thereof | Capsule - Fill Formulations | Japan | 6297441 |
Capsule Formulation | Capsule - Fill Formulations | Japan | 6588193 |
Delivery Carrier | Capsule - Fill Formulations | France | 2498760 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | Capsule - Fill Formulations | France | 3082778 |
Curcumin Solid Lipid Particles and Methods for their Preparation and Use | Capsule - Fill Formulations | France | 2964243 |
Delivery Carrier | Capsule - Fill Formulations | United Kingdom | 2498760 |
Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) | Capsule - Fill Formulations | United Kingdom | 3082778 |
Curcumin Solid Lipid Particles and Methods for their Preparation and Use | Capsule - Fill Formulations | United Kingdom | 2964243 |
Capsule Formulation | Capsule - Fill Formulations | United Kingdom | 3181125 |
Hard Capsule Formulation | Capsule - Fill Formulations | United Kingdom | 2988734 |
Capsule Formulation | Capsule - Fill Formulations | UPC Agreement | 3181125 |
Hard Capsule Formulation | Capsule - Fill Formulations | UPC Agreement | 2988734 |
Transfer Line | Capsule Manufacturing Process & Equipment | Germany | 602007040166.6 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Germany | 602007043597.8 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Germany | 602007009693.6 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Germany | 602011021060.2 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Germany | 3021108 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsule Manufacturing Process & Equipment | Germany | 3219300 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Germany | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Germany | 3709007 |
Transfer Line | Capsule Manufacturing Process & Equipment | United States | 8671650 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | United States | 8398912 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | United States | 8181425 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | United States | 8646591 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United States | 10113977 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United States | 9575011 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United States | 9414027 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsule Manufacturing Process & Equipment | United States | 10751255 |
Transfer Line | Capsule Manufacturing Process & Equipment | Belgium | 2457551 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Belgium | 2049313 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Belgium | 2049064 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Belgium | 2625509 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Belgium | 3021108 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | Belgium | 2358328 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsule Manufacturing Process & Equipment | Belgium | 3219300 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Belgium | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Belgium | 3709007 |
Transfer Line | Capsule Manufacturing Process & Equipment | Mexico | 301695 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Mexico | 298203 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Mexico | 291834 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | Mexico | 316978 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Netherlands | 3021108 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Netherlands | 2625509 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsule Manufacturing Process & Equipment | Netherlands | 3219300 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Netherlands | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Netherlands | 3709007 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Brazil | PI0715125-0 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Canada | 2660041 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Canada | 2660037 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | China | ZL200780029122.1 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | China | ZL201180059062.4 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Spain | 2049064 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsule Manufacturing Process & Equipment | Spain | 3219300 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Spain | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Spain | 3709007 |
Transfer Line | Capsule Manufacturing Process & Equipment | Italy | 2457551 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Italy | 2049064 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Italy | 2625509 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Italy | 3021108 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsule Manufacturing Process & Equipment | Italy | 3219300 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Italy | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Italy | 3709007 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | Japan | 5128596 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | Japan | 5197596 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | Japan | 5642081 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | Japan | 6000260 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsule Manufacturing Process & Equipment | Japan | 6895984 |
Transfer Line | Capsule Manufacturing Process & Equipment | France | 2457551 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | France | 2049313 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | France | 2049064 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | France | 3021108 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | France | 2625509 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | France | 2358328 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsule Manufacturing Process & Equipment | France | 3219300 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | France | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | France | 3709007 |
Transfer Line | Capsule Manufacturing Process & Equipment | United Kingdom | 2457551 |
Apparatus And Method For Removing Molded Articles From Their Molds | Capsule Manufacturing Process & Equipment | United Kingdom | 2049313 |
Method and Apparatus for Sealing Capsules | Capsule Manufacturing Process & Equipment | United Kingdom | 2049064 |
Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United Kingdom | 2625509 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United Kingdom | 3021108 |
Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus | Capsule Manufacturing Process & Equipment | United Kingdom | 2358328 |
Aseptic Hard Capsule Sealing Apparatus And Methods | Capsule Manufacturing Process & Equipment | United Kingdom | 3219300 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United Kingdom | 3715837 |
Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object | Capsule Manufacturing Process & Equipment | United Kingdom | 3709007 |
Process for Making Pullulan | Capsule Material (alternate poly.) | United States | 11319566 |
Process for Making Pullulan | Capsule Material (alternate poly.) | China | ZL201880024797.5 |
Process for Making Pullulan | Capsule Material (alternate poly.) | Japan | 7222911 |
Process for Making Pullulan | Capsule Material (alternate poly.) | Hong Kong | HK40016510 |
New Hard Capsules Comprising Pullulan | Capsules | Germany | 602012011096.1 |
Dosage Form Articles | Capsules | Germany | 3076954 |
Dosage Form Articles for Delayed Release | Capsules | Germany | 602014011687 |
Dosage Form Articles for External Mucosal Applications | Capsules | Germany | 3025709 |
Tamperproof Oral Dosage Form | Capsules | Germany | 3167869 |
Separable Capsule | Capsules | United States | 10568838 |
Separable Capsule | Capsules | United States | 9775813 |
Hard Capsules | Capsules | United States | 10130587 |
Hard Capsules | Capsules | United States | 10568839 |
Tamperproof Oral Dosage Form | Capsules | United States | 10470975 |
Tamperproof Oral Dosage Form | Capsules | United States | 10709640 |
Dosage Form Articles | Capsules | United States | 9980905 |
Dosage Form Articles for Delayed Release | Capsules | United States | 10555908 |
Dosage Form Articles for External Mucosal Applications | Capsules | United States | 10525011 |
Colloidal Dispersion Comprising HPMCAS | Capsules | United States | 10471152 |
Separable Capsule For Sprinkling Applications | Capsules | United States | 10610490 |
New Hard Capsules Comprising Pullulan | Capsules | Belgium | 2663294 |
Dosage Form Articles | Capsules | Belgium | 3076954 |
Dosage Form Articles for Delayed Release | Capsules | Belgium | 3028694 |
Dosage Form Articles for External Mucosal Applications | Capsules | Belgium | 3025709 |
Tamperproof Oral Dosage Form | Capsules | Belgium | 3167869 |
Pullulan Capsules | Capsules | Poland | 4304563 |
New Hard Capsules Comprising Pullulan | Capsules | Netherlands | 2663294 |
Separable Capsule | Capsules | Canada | 2900305 |
Dosage Form Articles for External Mucosal Applications | Capsules | Canada | 2965425 |
HPMC Capsule With Reduced Powder Retention | Capsules | Switzerland | 4106734 |
Separable Capsule | Capsules | Switzerland | 2994114 |
Capsule With Reduced Powder Leakage | Capsules | Switzerland | 4069178 |
Pullulan Capsules | Capsules | Switzerland | 4304563 |
New Hard Capsules Comprising Pullulan | Capsules | Spain | 2663294 |
HPMC Capsule With Reduced Powder Retention | Capsules | Spain | 4106734 |
Separable Capsule | Capsules | Spain | 2994114 |
Capsule With Reduced Powder Leakage | Capsules | Spain | 4069178 |
Pullulan Capsules | Capsules | Spain | 4304563 |
New Hard Capsules Comprising Pullulan | Capsules | Italy | 2663294 |
Separable Capsule | Capsules | Japan | 6436977 |
New Hard Capsules Comprising Pullulan | Capsules | Japan | 5860480 |
Tamperproof Oral Dosage Form | Capsules | Japan | 6905513 |
Tamperproof Oral Dosage Form | Capsules | Japan | 6905512 |
Dosage Form Articles for External Mucosal Applications | Capsules | Japan | 6706254 |
Cellulose Derivative Base Hard Capsule Improved In Mechanical Strength And Oxygen Impermeability | Capsules | Japan | 7397886 |
Capsule With Reduced Powder Leakage | Capsules | Japan | 7592091 |
New Hard Capsules Comprising Pullulan | Capsules | France | 2663294 |
Dosage Form Articles | Capsules | France | 3076954 |
Dosage Form Articles for Delayed Release | Capsules | France | 3028694 |
Dosage Form Articles for External Mucosal Applications | Capsules | France | 3025709 |
Tamperproof Oral Dosage Form | Capsules | France | 3167869 |
New Hard Capsules Comprising Pullulan | Capsules | United Kingdom | 2663294 |
Dosage Form Articles | Capsules | United Kingdom | 3076954 |
Dosage Form Articles for Delayed Release | Capsules | United Kingdom | 3028694 |
Dosage Form Articles for External Mucosal Applications | Capsules | United Kingdom | 3025709 |
Tamperproof Oral Dosage Form | Capsules | United Kingdom | 3167870 |
HPMC Capsule With Reduced Powder Retention | Capsules | United Kingdom | 4106734 |
Separable Capsule | Capsules | United Kingdom | 2994114 |
Capsule With Reduced Powder Leakage | Capsules | United Kingdom | 4069178 |
Tamperproof Oral Dosage Form | Capsules | United Kingdom | 3167869 |
Pullulan Capsules | Capsules | United Kingdom | 4304563 |
Sprinkle Design | Capsules | United Kingdom | 90025425220004 |
Sprinkle Design | Capsules | United Kingdom | 90025425220001 |
Sprinkle Design | Capsules | United Kingdom | 90025425220006 |
Sprinkle Design | Capsules | United Kingdom | 90025425220003 |
Sprinkle Design | Capsules | United Kingdom | 90025425220007 |
Sprinkle Design | Capsules | United Kingdom | 90025425220005 |
Sprinkle Design | Capsules | United Kingdom | 90025425220002 |
Capsule With Reduced Powder Leakage | Capsules | Croatia | 4069178 |
Sprinkle Design | Capsules | EUIPO | 002542522-0004 |
Sprinkle Design | Capsules | EUIPO | 002542522-0005 |
Sprinkle Design | Capsules | EUIPO | 002542522-0002 |
Sprinkle Design | Capsules | EUIPO | 002542522-0006 |
Sprinkle Design | Capsules | EUIPO | 002542522-0007 |
Sprinkle Design | Capsules | EUIPO | 002542522-0003 |
Sprinkle Design | Capsules | EUIPO | 002542522-0001 |
Print or Label for a Capsule Surface (Vertical) | Capsules | EUIPO | 003107515-0001 |
Print or Label for a Capsule Surface (Vertical) | Capsules | EUIPO | 003107515-0002 |
Capsule Comprising A Print Or Label (Dotted Lines) | Capsules | EUIPO | 003108505-0001 |
Capsule Comprising A Print Or Label (Dotted Lines) | Capsules | EUIPO | 003108505-0002 |
Tamperproof Oral Dosage Form | Capsules | UPC Agreement | 3167870 |
HPMC Capsule With Reduced Powder Retention | Capsules | UPC Agreement | 4106734 |
Separable Capsule | Capsules | UPC Agreement | 2994114 |
Capsule With Reduced Powder Leakage | Capsules | UPC Agreement | 4069178 |
Pullulan Capsules | Capsules | UPC Agreement | 4304563 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | Germany | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | United States | 10603286 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | United States | 11406601 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | United States | 11975107 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | Belgium | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | Netherlands | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | Brazil | BR112018014719-2 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | Canada | 3011656 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | Switzerland | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | Spain | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | Italy | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | Japan | 7263465 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | France | 3199148 |
Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates | Capsules - Color | United Kingdom | 3199148 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Germany | 2480218 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | United States | 9700517 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | United States | 10231934 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | United States | 10874619 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | United States | 8852631 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Belgium | 2480218 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Poland | 2480218 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Mexico | 334274 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Netherlands | 2480218 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Brazil | BR112012006651-0 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Canada | 2775227 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | China | ZL201080042764.7 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Spain | 2480218 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | India | 342484 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Italy | 2480218 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Japan | 5777625 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | France | 2480218 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | United Kingdom | 2480218 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Czech Republic | 2480218 |
Acid Resistant Capsules | Capsules - DRcaps® capsules | Korea - South | 10-1762460 |
Device For Dispensing Single Droplets Into A Cap Or Body Of A Capsule | Capsule Sealing | United States | 12103723 |
Sealing Fluid For Sealing Capsules | Capsule Sealing | Poland | 4225276 |
Sealing Fluid For Sealing Capsules | Capsule Sealing | Switzerland | 4225276 |
Device For Dispensing Single Droplets Into A Cap Or Body Of A Capsule | Capsule Sealing | Switzerland | 4196073 |
Sealing Fluid For Sealing Capsules | Capsule Sealing | Spain | 4225276 |
Device For Dispensing Single Droplets Into A Cap Or Body Of A Capsule | Capsule Sealing | Spain | 4196073 |
Sealing Fluid For Sealing Capsules | Capsule Sealing | United Kingdom | 4225276 |
Device For Dispensing Single Droplets Into A Cap Or Body Of A Capsule | Capsule Sealing | United Kingdom | 4196073 |
Sealing Fluid For Sealing Capsules | Capsule Sealing | UPC Agreement | 4225276 |
Device For Dispensing Single Droplets Into A Cap Or Body Of A Capsule | Capsule Sealing | UPC Agreement | 4196073 |
Gelatin Capsules And Gelatin Compositions For Forming Capsule Coating | Capsules - Gelatin | Japan | 5766205 |
Container | Capsules - Licaps® capsules | Germany | 602006038698.2 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Germany | 602009008078.4 |
Container | Capsules - Licaps® capsules | United States | 8377471 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | United States | 8715722 |
Container | Capsules - Licaps® capsules | Belgium | 1915121 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Belgium | 2276445 |
Container | Capsules - Licaps® capsules | Mexico | 309351 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Mexico | 315642 |
Container | Capsules - Licaps® capsules | Netherlands | 1915121 |
Container | Capsules - Licaps® capsules | Brazil | PI0614735-6 |
Container | Capsules - Licaps® capsules | Canada | 2617967 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Canada | 2722271 |
Container | Capsules - Licaps® capsules | China | ZL201210011817.X |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | China | ZL200980117292.4A |
Container | Capsules - Licaps® capsules | Spain | 1915121 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Spain | 2276445 |
Container | Capsules - Licaps® capsules | India | 272531 |
Container | Capsules - Licaps® capsules | Italy | 1915121 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Italy | 2276445 |
Container | Capsules - Licaps® capsules | Japan | 5006913 |
Container | Capsules - Licaps® capsules | Japan | 4422779 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Japan | 5716212 |
Container | Capsules - Licaps® capsules | France | 1915121 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | France | 2276445 |
Container | Capsules - Licaps® capsules | United Kingdom | 1915121 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | United Kingdom | 2276445 |
Improved Capsule with Air-Vents | Capsules - Licaps® capsules | Korea - South | 1012359510000 |
Film Coating For Tablets And Caplets | Capsules - Press-Fit® Capsules | United States | 7914820 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Germany | 2078042 |
Capsule Formation | Capsules - Vcaps® capsules | Germany | 602007011963.4 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Germany | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | United States | 9655860 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | United States | 10004692 |
Capsule Formation | Capsules - Vcaps® capsules | United States | 9211659 |
Capsule Formation | Capsules - Vcaps® capsules | United States | 9138920 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Belgium | 2078042 |
Capsule Formation | Capsules - Vcaps® capsules | Belgium | 2083786 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Belgium | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Mexico | 315891 |
Capsule Formation | Capsules - Vcaps® capsules | Mexico | 298202 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Netherlands | 2078042 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Netherlands | 3594248 |
Hydroxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Canada | 2667167 |
Capsule Formation | Capsules - Vcaps® capsules | Canada | 2667531 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Switzerland | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | China | ZL200780040028.6 |
Capsule Formation | Capsules - Vcaps® capsules | China | ZL200780040046.4 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Spain | 3594248 |
Hyrdorxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Indonesia | IDP000039591 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | India | 288423 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Italy | 2078042 |
Capsule Formation | Capsules - Vcaps® capsules | Italy | 2083786 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Italy | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Japan | 5372761 |
Capsule Formation | Capsules - Vcaps® capsules | Japan | 5452227 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | France | 2078042 |
Capsule Formation | Capsules - Vcaps® capsules | France | 2083786 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | France | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | United Kingdom | 2078042 |
Capsule Formation | Capsules - Vcaps® capsules | United Kingdom | 2083786 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | United Kingdom | 3594248 |
Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture | Capsules - Vcaps® capsules | Korea - South | 1011702830000 |
Capsule Formation | Capsules - Vcaps® capsules | Korea - South | 1183713 |
Weighing Apparatus With Improved Cleaning Capabilities | Capsules - Xcelodose® System | United States | 7834279 |
Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | United States | 8074835 |
Apparatus And Method For Dispensing Small Quantities Of Particles | Capsules - Xcelodose® System | United States | 7712634 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Germany | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | United States | 8470382 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | United States | 9066868 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Netherlands | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Taiwan | I469797 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Switzerland | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | China | ZL201080056055.4 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Spain | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | India | 295113 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Italy | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Japan | 5911806 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Japan | 6239579 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | France | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | United Kingdom | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Czech Republic | 2509436 |
Carnitine Granulate and Methods for its Production | CARNIKING® L-carnitine | Korea - South | 10-1761958 |
Process for the Production of a Fatty Acid/Carnitine Derivative | Carnitine Derivative Manufacturing Process | Germany | 602010004833.0 |
Process for the Production of a Fatty Acid/Carnitine Derivative | Carnitine Derivative Manufacturing Process | United States | 8614343 |
Process for the Production of a Fatty Acid/Carnitine Derivative | Carnitine Derivative Manufacturing Process | China | ZL201080006619.3 |
Process for the Production of a Fatty Acid/Carnitine Derivative | Carnitine Derivative Manufacturing Process | Korea - South | 10-1699990 |
Process for the Preparation of Betaines | Carnitine Manufacturing | Germany | 602008009662.9 |
A Process for the Enzymatic Production of Carnitine from ß-Lactones | Carnitine Manufacturing | Germany | 2737074 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnitine Manufacturing | Germany | 2702032 |
A Process for the Hydrogenation of Ketoesters | Carnitine Manufacturing | Germany | 2569275 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnitine Manufacturing | Germany | 2393578 |
Methods for Decolorizing Compositions Comprising Be-taines | Carnitine Manufacturing | Germany | 2920143 |
Process for the Preparation of Betaines | Carnitine Manufacturing | United States | 8168823 |
A Process for the Enzymatic Production of Carnitine from ß-Lactones | Carnitine Manufacturing | United States | 9523106 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnitine Manufacturing | United States | 9227905 |
A Process for the Hydrogenation of Ketoesters | Carnitine Manufacturing | United States | 8431741 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnitine Manufacturing | United States | 9415346 |
Methods for Decolorizing Compositions Comprising Betaines | Carnitine Manufacturing | United States | 9550726 |
Process for the Preparation of Betaines | Carnitine Manufacturing | China | ZL200880117375.9 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnitine Manufacturing | China | ZL201280020003.0 |
A Process for the Hydrogenation of Ketoesters | Carnitine Manufacturing | China | ZL201180019495.7 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnitine Manufacturing | China | ZL201080006621.0 |
Methods for Decolorizing Compositions Comprising Be-taines | Carnitine Manufacturing | China | ZL201380057952.0 |
Process for the Preparation of Betaines | Carnitine Manufacturing | India | 271284 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnitine Manufacturing | India | 308970 |
A Process for the Hydrogenation of Ketoesters | Carnitine Manufacturing | India | 292185 |
Process for the Production of 4-Chloroacetyl Chloride, 4-Chloroacetic Acid Esters, Amides and Imides | Carnitine Manufacturing | Japan | 6012709 |
Process for the Preparation of Betaines | Carnitine Manufacturing | Korea - South | 1132589 |
A Process for the Hydrogenation of Ketoesters | Carnitine Manufacturing | Korea - South | 10-1848763 |
Process for the Recovery of Betaines from Electrodialysis Waste Streams | Carnitine Manufacturing | Korea - South | 10-1728562 |
Process for the Production of L-Carnitine Tartrate | Carnitine Tartrate Manufacturing Process | Germany | 2613778 |
Process for the Production of L-Carnitine Tartrate | Carnitine Tartrate Manufacturing Process | United States | 8779188 |
Process for the Production of L-Carnitine Tartrate | Carnitine Tartrate Manufacturing Process | Switzerland | 2613778 |
Process for the Production of L-Carnitine Tartrate | Carnitine Tartrate Manufacturing Process | China | ZL201180042646.0 |
Process for the Production of L-Carnitine Tartrate | Carnitine Tartrate Manufacturing Process | India | 293603 |
Process for the Production of L-Carnitine Tartrate | Carnitine Tartrate Manufacturing Process | Italy | 2613778 |
Process for the Production of L-Carnitine Tartrate | Carnitine Tartrate Manufacturing Process | Japan | 5964831 |
Process for the Production of L-Carnitine Tartrate | Carnitine Tartrate Manufacturing Process | Czech Republic | 2613778 |
Process for the Production of L-Carnitine Tartrate | Carnitine Tartrate Manufacturing Process | Korea - South | 10-1899015 |
Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function | Carnitine Use | Germany | 2694051 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | Carnitine Use | Germany | 3154539 |
Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function | Carnitine Use | United States | 10130602 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | Carnitine Use | United States | 10016382 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | Carnitine Use | Canada | 2951567 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | Carnitine Use | Spain | 3154539 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | Carnitine Use | Italy | 3154539 |
Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function | Carnitine Use | Japan | 6608858 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | Carnitine Use | Japan | 6982956 |
Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function | Carnitine Use | France | 2694051 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | Carnitine Use | France | 3154539 |
Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function | Carnitine Use | United Kingdom | 2694051 |
Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals | Carnitine Use | United Kingdom | 3154539 |
Scalable Process for Therapeutic Cell Concentration and Residual Clearance | Cell and Gene Therapies | United States | 10385307 |
Cell Culture System and Method | Cell and Gene Therapies | United States | 11559811 |
Methods for Nuclear Reprogramming Using Synthetic Transcription Factors | Cell and Gene Therapies | United States | 11655481 |
Methods for Nuclear Reprogramming Using Synthetic Transcription Factors | Cell and Gene Therapies | Canada | 2985714 |
Cell Culture System and Method | Cell and Gene Therapies | China | ZL201880018683.X |
Cell Culture System and Method | Cell and Gene Therapies | Israel | 268433 |
Methods for Nuclear Reprogramming Using Synthetic Transcription Factors | Cell and Gene Therapies | Israel | 255536 |
Perfusion Apparatus for Use in Bioreactor Systems | Cell and Gene Therapies | Israel | IL273548 |
Methods for Nuclear Reprogramming Using Synthetic Transcription Factors | Cell and Gene Therapies | Israel | 298524 |
Perfusion Apparatus for Use in Bioreactor Systems | Cell and Gene Therapies | Japan | 7335873 |
Allogeneic T-Cells and Methods for Production Thereof | Cell and Gene Therapies | Japan | 7681015 |
Cell Culture System and Method | Cell and Gene Therapies | Japan | 7350142 |
Cell Culture System and Method | Cell and Gene Therapies | Korea - South | 10-2499475 |
Perfusion Apparatus for Use in Bioreactor Systems | Cell and Gene Therapies | Korea - South | 10-2604994 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Germany | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | United States | 9512474 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Netherlands | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Sweden | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Switzerland | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Spain | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | Italy | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | France | 2761024 |
Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing | Cell and Gene Therapies - Bio Assays | United Kingdom | 2761024 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Germany | 2718424 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Germany | 3047020 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | United States | 10487312 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | United States | 9885019 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | United States | 11976303 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | United States | 10745668 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Australia | 2016238891 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Australia | 2012255724 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Netherlands | 2718424 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Netherlands | 3047020 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Sweden | 2718424 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Sweden | 3047020 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Canada | 2836578 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Canada | 2924735 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Switzerland | 2718424 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Switzerland | 3047020 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | China | ZL201480063730.4 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | China | ZL202010068504.2 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Spain | 2718424 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Spain | 3047020 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Israel | 229462 |
Passaging and Harvesting Formulation for Single-Cell Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Israel | 267628 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Italy | 2718424 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Italy | 3047020 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Japan | 6140149 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | Japan | 6479775 |
Passaging and Harvesting Formulation for Single-Cell Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Japan | 7092309 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | France | 2718424 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | France | 3047020 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | United Kingdom | 2718424 |
Methods for Nuclear Reprogramming of Cells | Cell and Gene Therapies - iPSC | United Kingdom | 3047020 |
Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Korea - South | 10-1970368 |
Passaging and Harvesting Formulation for Single-Cell Human Pluripotent Stem Cells | Cell and Gene Therapies - iPSC | Korea - South | 10-2580997 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | Germany | 3464571 |
Mammalian Cells For Producing Adeno-Associated Viruses | Cell and Gene Therapies - Viral Vector Manufacturing | United States | 11781116 |
Adeno-Associated Virus (AAV) Producer Cell Line and Related Methods | Cell and Gene Therapies - Viral Vector Manufacturing | United States | 11739347 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | United States | 11427809 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | Australia | 2017269371 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | Switzerland | 3464571 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | China | ZL201780032195.X |
Mammalian Cells For Producing Adeno-Associated Viruses | Cell and Gene Therapies - Viral Vector Manufacturing | Israel | 268525 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | Israel | 262960 |
Mammalian Cells For Producing Adeno-Associated Viruses | Cell and Gene Therapies - Viral Vector Manufacturing | Japan | 7637470 |
Adeno-Associated Virus (AAV) Producer Cell Line and Related Methods | Cell and Gene Therapies - Viral Vector Manufacturing | Japan | 7650800 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | Japan | 6908331 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | France | 3464571 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | United Kingdom | 3464571 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | Hong Kong | HK40000235 |
Mammalian Cells For Producing Adeno-Associated Viruses | Cell and Gene Therapies - Viral Vector Manufacturing | Korea - South | 10-2719587 |
Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt | Cell and Gene Therapies - Viral Vector Manufacturing | Korea - South | 10-2450255 |
Advanced Tissue Engineering System | Cocoon® Platform | United States | 9499780 |
End-To-End Cell Therapy Automation | Cocoon® Platform | United States | 11371018 |
End-To-End Cell Therapy Automation | Cocoon® Platform | United States | 11447745 |
Automated Cell Culture System | Cocoon® Platform | United States | 9783768 |
Automated Production of Viral Vectors | Cocoon® Platform | United States | 11718833 |
Cell Concentration Methods and Devices for UseiIn Automated Bioreactors | Cocoon® Platform | United States | 11773365 |
Cell Culture and Tissue Engineering Systems with Controlled Environmental Zones | Cocoon® Platform | United States | 11597905 |
Quality Control Methods for Automated Cell Processing | Cocoon® Platform | United States | 12163146 |
Cell Culture Chamber with Improved Cell-Contacting Surfaces | Cocoon® Platform | United States | 12247188 |
Carousel for Modular Biologic Production Units | Cocoon® Platform | United States | 11714096 |
Polymeric Carriers and Methods | Cocoon® Platform | United States | 11560545 |
Cell Culture and Tissue Engineering Systems with Controlled Environmental Zones | Cocoon® Platform | United States | 12098359 |
End-To-End Cell Therapy Automation | Cocoon® Platform | United States | 11827902 |
End-To-End Cell Therapy Automation | Cocoon® Platform | United States | 11781113 |
Support For Biologic Engineering Unit | Cocoon® Platform | United States | D1057994S |
Automated Production of Viral Vectors | Cocoon® Platform | United States | 12180511 |
Carousel for Modular Biologic Production Units | Cocoon® Platform | United States | 12306198 |
Cell Culture and Tissue Engineering Systems with Controlled Environmental Zones | Cocoon® Platform | Singapore | 11202106652W |
Automated Production of Viral Vectors | Cocoon® Platform | Singapore | 11202106377X |
Magnetic Separation | Cocoon® Platform | Singapore | 11202102841W |
Support For Biologic Engineering Unit | Cocoon® Platform | Singapore | 30202250206G |
End-To-End Cell Therapy Automation | Cocoon® Platform | Canada | 3074448 |
Automated Cell Culture System | Cocoon® Platform | Canada | 2833001 |
Support For Biologic Engineering Unit | Cocoon® Platform | Canada | 214427 |
End-To-End Cell Therapy Automation | Cocoon® Platform | Canada | 3185343 |
Carousel for Modular Biologic Production Units | Cocoon® Platform | China | ZL201980090559.9 |
Cell Culture and Tissue Engineering Systems with Controlled Environmental Zones | Cocoon® Platform | China | ZL201980086836.9 |
Magnetic Separation | Cocoon® Platform | China | ZL201980063896.9 |
Support For Biologic Engineering Unit | Cocoon® Platform | China | ZL202230469207.9 |
End-To-End Cell Therapy Automation | Cocoon® Platform | Israel | 272914 |
Carousel for Modular Biologic Production Units | Cocoon® Platform | Israel | 284214 |
Support For Biologic Engineering Unit | Cocoon® Platform | Israel | 69141 |
Cell Concentration Methods and Devices for Use in Automated Bioreactors | Cocoon® Platform | Japan | 7536026 |
Automated Production of Viral Vectors | Cocoon® Platform | Japan | 7598864 |
Carousel for Modular Biologic Production Units | Cocoon® Platform | Japan | 7477091 |
Cell Culture and Tissue Engineering Systems with Controlled Environmental Zones | Cocoon® Platform | Japan | 7477092 |
Magnetic Separation | Cocoon® Platform | Japan | 7396777 |
Support For Biologic Engineering Unit | Cocoon® Platform | Japan | D1745550 |
End-To-End Cell Therapy Automation | Cocoon® Platform | Japan | 7368066 |
Cell Culture Chamber with Improved Cell-Contacting Surfaces | Cocoon® Platform | Japan | 7696340 |
Magnetic Separation | Cocoon® Platform | Japan | 7691475 |
Support For Biologic Engineering Unit | Cocoon® Platform | United Kingdom | 6221024 |
Carousel for Modular Biologic Production Units | Cocoon® Platform | Hong Kong | 40050777 |
Support For Biologic Engineering Unit | Cocoon® Platform | EUIPO | 009095987-0001 |
End-To-End Cell Therapy Automation | Cocoon® Platform | Korea - South | 10-2296580 |
End-To-End Cell Therapy Automation | Cocoon® Platform | Korea - South | 10-2546681 |
Magnetic Separation | Cocoon® Platform | Korea - South | 10-2816402 |
Support For Biologic Engineering Unit | Cocoon® Platform | Korea - South | 30-1222485 |
Cell Culture and Tissue Engineering Systems with Controlled Environmental Zones | Cocoon® Platform | Korea - South | 10-2810534 |
End-To-End Cell Therapy Automation | Cocoon® Platform | Korea - South | 10-2827438 |
Process for the Cycloaddition of a Hetero(Aryl) 1,3-Dipole Compound With a (Hetero)Cycloalkyne | Conjugation Technology | Germany | 60 2015 069 203.9 |
Bicyclo[6.1.0]Non-4-Yne Reagents for Chemical Modification of Oligonucleotides | Conjugation Technology | Germany | 2753607 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Germany | 2894142 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Germany | 2563753 |
Process for the Cycloaddition of a Hetero(Aryl) 1,3-Dipole Compound With a (Hetero)Cycloalkyne | Conjugation Technology | United States | 12084448 |
Process for the Cycloaddition of a Hetero(Aryl) 1,3-Dipole Compound With a (Hetero)Cycloalkyne | Conjugation Technology | United States | 11168085 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | United States | 12180145 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | United States | 11358921 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | United States | 10239807 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | United States | 9222940 |
Bicyclo[6.1.0]Non-4-Yne Reagents for Chemical Modification of Oligonucleotides | Conjugation Technology | Belgium | 2753607 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Belgium | 2563753 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Poland | 2563753 |
Process for the Cycloaddition of a Hetero(Aryl) 1,3-Dipole Compound With a (Hetero)Cycloalkyne | Conjugation Technology | Netherlands | 3097079 |
Bicyclo[6.1.0]Non-4-Yne Reagents for Chemical Modification of Oligonucleotides | Conjugation Technology | Netherlands | 2753607 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Netherlands | 2563753 |
Tyrosine-Based Antibody Conjugates | Conjugation Technology | Netherlands | 2026947 |
Methods for the Preparation of Bioconjugates | Conjugation Technology | Netherlands | 2026400 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Sweden | 2563753 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Turkey | TR 2015 00623 T4 |
Process for the Cycloaddition of a Hetero(Aryl) 1,3-Dipole Compound With a (Hetero)Cycloalkyne | Conjugation Technology | Switzerland | 3097079 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Switzerland | 2563753 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | China | 2017100378165 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | China | 2011800319632 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Spain | 2563753 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Ireland | 2563753 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | India | 469262 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | India | 342991 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Italy | 502014000003800 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Japan | 5920936 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Finland | 2563753 |
Process for the Cycloaddition of a Hetero(Aryl) 1,3-Dipole Compound With a (Hetero)Cycloalkyne | Conjugation Technology | France | 3097079 |
Bicyclo[6.1.0]Non-4-Yne Reagents for Chemical Modification of Oligonucleotides | Conjugation Technology | France | 2753607 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | France | 2894142 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | France | 2563753 |
Process for the Cycloaddition of a Hetero(Aryl) 1,3-Dipole Compound With a (Hetero)Cycloalkyne | Conjugation Technology | United Kingdom | 3097079 |
Bicyclo[6.1.0]Non-4-Yne Reagents for Chemical Modification of Oligonucleotides | Conjugation Technology | United Kingdom | 2753607 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | United Kingdom | 2894142 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | United Kingdom | 2563753 |
Fused Cyclooctyne Compounds and Their Use in Metal-Free Click Reactions | Conjugation Technology | Denmark | 2563753 |
Device and Method for Improved Closure Integrity | Container Testing | Germany | 3681571 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | Germany | 3884252 |
Device and Method for Improved Container Closure Integrity Testing | Container Testing | Germany | 3682219 |
Displacement Device, Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe | Container Testing | Germany | 3911382 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | United States | 11499885 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | United States | 11346742 |
Device and Method for Improved Closure Integrity Testing | Container Testing | United States | 10801913 |
Device and Method for Improved Container Closure Integrity Testing | Container Testing | United States | 10895514 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | United States | 11852564 |
Displacement Device, Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe | Container Testing | United States | 11389599 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | Netherlands | 3884252 |
Displacement Device, Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe | Container Testing | Netherlands | 3911382 |
Device and Method for Improved Closure Integrity | Container Testing | Switzerland | 3681571 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | Switzerland | 3884252 |
Device and Method for Improved Container Closure Integrity Testing | Container Testing | Switzerland | 3682219 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | Switzerland | 3899474 |
Displacement Device, Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe | Container Testing | Switzerland | 3911382 |
Device and Method for Improved Closure Integrity | Container Testing | China | ZL201880059976.2 |
Device and Method for Improved Container Closure Integrity Testing | Container Testing | China | ZL201880059371.3 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | Spain | 3884252 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | Spain | 3899474 |
Displacement Device, Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe | Container Testing | Spain | 3911382 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | Italy | 3884252 |
Displacement Device, Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe | Container Testing | Italy | 3911382 |
Device and Method for Improved Closure Integrity | Container Testing | Japan | 7042901 |
Device and Method for Improved Container Closure Integrity Testing | Container Testing | Japan | 6983310 |
Device and Method for Improved Closure Integrity | Container Testing | France | 3681571 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | France | 3884252 |
Device and Method for Improved Container Closure Integrity Testing | Container Testing | France | 3682219 |
Displacement Device, Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe | Container Testing | France | 3911382 |
Device and Method for Improved Closure Integrity | Container Testing | United Kingdom | 3681571 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | United Kingdom | 3884252 |
Device and Method for Improved Container Closure Integrity Testing | Container Testing | United Kingdom | 3682219 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | United Kingdom | 3899474 |
Displacement Device, Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe | Container Testing | United Kingdom | 3911382 |
Device and Method for Improved Closure Integrity | Container Testing | Hong Kong | HK40025040 |
Device and Method for Improved Container Closure Integrity Testing | Container Testing | Hong Kong | HK40025036 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container | Container Testing | UPC Agreement | 3899474 |
Methods Of Measuring Extracellular Vesicles And Nanoparticles In Complex Matrices By Light Scattering | Detecting Exosomes | United States | 12066382 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | Germany | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | United States | 10159244 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | Sweden | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | Canada | 2978080 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | Switzerland | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | China | ZL201680082606.1 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | Spain | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | India | 385511 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | Italy | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | Japan | 6733872 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | France | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | United Kingdom | 3262156 |
Method for Pooling Hepatocytes | DonorPlex® Pooled Donor Hepatocytes | Hong Kong | HK1248765 |
Immediate Release Dosage Forms Containing Solid Drug Dispersions | Dosage Form | United States | 9211261 |
Formulations To Achieve Rapid Dissolution Of Drug From Spray-Dried Dispersions In Capsules | Dosage Form | United States | 12133911 |
Formulations To Achieve Rapid Dissolution Of Drug From Spray-Dried Dispersions In Capsules | Dosage Form | Canada | 2987867 |
Formulations To Achieve Rapid Dissolution Of Drug From Spray-Dried Dispersions In Capsules | Dosage Form | Japan | 6796083 |
Solid Dosage Forms With High Active Agent Loading | Drug Product - SDF | Canada | 3098306 |
Solid Dosage Forms With High Active Agent Loading | Drug Product - SDF | China | ZL201980032838.X |
Solid Dosage Forms With High Active Agent Loading | Drug Product - SDF | Japan | 7333340 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | Germany | 3552021 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Germany | 3494226 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate and Chromogenic Assay of Endotoxin | Endotoxin Detection | United States | 11352656 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | United States | 11906521 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | United States | 11156614 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | Netherlands | 3552021 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Netherlands | 3494226 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | Sweden | 3552021 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Sweden | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Singapore | 11201900767V |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | Switzerland | 3552021 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Switzerland | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Switzerland | 3943608 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | China | ZL201880006683.8 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | China | ZL201780048853.4 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | Israel | 267593 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Israel | 264464 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | Italy | 3552021 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Italy | 3494226 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | Japan | 7507560 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Japan | 7044222 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | France | 3552021 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | France | 3494226 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | United Kingdom | 3552021 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | United Kingdom | 3494226 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | United Kingdom | 3943608 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | Hong Kong | HK40007693 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Hong Kong | HK40006346 |
Coagulogen-Free Clarified Limulus Amebocyte Lysate | Endotoxin Detection | Korea - South | 10-2545029 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | Korea - South | 10-2561368 |
Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen | Endotoxin Detection | UPC Agreement | 3943608 |
Process For Preparing Extracellular Vesicles | Exosome Manufacturing | United States | 12233356 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | Germany | 602019008206.1 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Germany | 602018042683.3 |
Preparation Of Therapeutic Exosomes Using Membrane Proteins | Exosomes | United States | 12257313 |
Methods and Compositions for Macrophage Polarization | Exosomes | United States | 11512315 |
Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy | Exosomes | United States | 10723782 |
Methods Of Measuring Exosomes Using Intrinsic Fluorescence | Exosomes | United States | 12158424 |
Preparation Of Therapeutic Exosomes Using Membrane Proteins | Exosomes | United States | 11679164 |
Preparation Of Therapeutic Exosomes Using Membrane Proteins | Exosomes | United States | 10561740 |
Preparation Of Therapeutic Exosomes Using Membrane Proteins | Exosomes | United States | 10195290 |
Delivery Of Therapeutic Agent | Exosomes | United States | 10370663 |
Delivery Of Therapeutic Agent | Exosomes | United States | 9856477 |
Exosome Transfer Of Nucleic Acids To Cells | Exosomes | United States | 10695443 |
Exosome Transfer Of Nucleic Acids To Cells | Exosomes | United States | 9889210 |
Exosome Transfer Of Nucleic Acids To Cells | Exosomes | United States | 9085778 |
Exosome Transfer Of Nucleic Acids To Cells | Exosomes | United States | 9629929 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Austria | 3684381 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Belgium | 3684381 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Portugal | 3684381 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | Netherlands | 3672614 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Netherlands | 3684381 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Norway | 3684381 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Sweden | 3684381 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | Switzerland | 3672614 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Switzerland | 3684381 |
Methods and Compositions for Macrophage Polarization | Exosomes | China | ZL201980011011.0 |
Compositions Of Engineered Exosomes And Methods Of Loading Lumenal Exosome Payloads | Exosomes | China | ZL201880072250.2 |
Preparation Of Therapeutic Exosomes Using Membrane Proteins | Exosomes | China | ZL201880055135.4 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | Spain | 3672614 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Spain | E18858922 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Ireland | 3684381 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | Iceland | 3672614 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Italy | 3684381 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Finland | 3684381 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | France | 3672614 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | France | 3684381 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | United Kingdom | 3672614 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | United Kingdom | 3684381 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | United Kingdom | 4059510 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | Hong Kong | HK40032716 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Hong Kong | HK40034682 |
Production Of Extracellular Vesicles In Single-Cell Suspension Using Chemically-Defined Cell Culture Media | Exosomes | Denmark | 3684381 |
Engineered Extracellular Vesicles And Uses Thereof | Exosomes | UPC Agreement | 4059510 |
Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy | Exosomes for Oncology Use | United States | 12331100 |
Exosomes for Immuno-Oncology and Anti-Inflammatory Therapy | Exosomes for Oncology Use | United States | 12030924 |
Extracellular Vesicles for Vaccine Delivery | Exosomes for Vaccine | United States | 11992527 |
Extracellular Vesicle Conjugates and Uses Thereof | Exosome with Active Moiety | China | CN113747925 |
Extracellular Vesicle Linked to Molecules and Uses Thereof | Exosome with Linkers | China | CN114728078B |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | Germany | 1839739 |
Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate® Microreactor Technology | Germany | 3031518 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | United States | 8287824 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | United States | 7919056 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | United States | 9962678 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | United States | 9375698 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | United States | 8512653 |
Method For Preventing Plugging Of A Continuous-Reaction Channel-System And Micro-Reactor For Carrying Out The Method | FlowPlate® Microreactor Technology | United States | 10058840 |
Continuous Reaction Micro-Reactor | FlowPlate® Microreactor Technology | United States | 9302243 |
Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate® Microreactor Technology | United States | 9023296 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | China | ZL200780012236.5 |
Continuous Reaction Micro-Reactor | FlowPlate® Microreactor Technology | China | ZL201080017207.X |
Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate® Microreactor Technology | China | ZL201080020562.2 |
Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate® Microreactor Technology | China | ZL201580066933.3 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | Japan | 6234959 |
Method For Preventing Plugging Of A Continuous-Reaction Channel-System And Micro-Reactor For Carrying Out The Method | FlowPlate® Microreactor Technology | Japan | 5718335 |
Continuous Reaction Micro-Reactor | FlowPlate® Microreactor Technology | Japan | 5774580 |
Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate® Microreactor Technology | Japan | 6062244 |
Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate® Microreactor Technology | Japan | 6759208 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | France | 1839739 |
Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate® Microreactor Technology | France | 3031518 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | United Kingdom | 1839739 |
Fluid Mixing Structure, Continuous Reaction Unit, Continuous Reaction Reactor And Method Of Using The Same | FlowPlate® Microreactor Technology | United Kingdom | 3031518 |
Micro-Reactor System Assembly | FlowPlate® Microreactor Technology | Hong Kong | HK1128007 |
Continuous Reaction Micro-Reactor | FlowPlate® Microreactor Technology | Hong Kong | HK1164779 |
Method Of Manufacturing A Reactor And Set Of Reactors | FlowPlate® Microreactor Technology | Hong Kong | HK1170447 |
Stable Dosage Form Articles for Oral Administration | Gelatin Capsule with Fill Formulation | Germany | 3151815 |
Stable Dosage Form Articles for Oral Administration | Gelatin Capsule with Fill Formulation | United States | 10016369 |
Stable Dosage Form Articles for Oral Administration | Gelatin Capsule with Fill Formulation | Belgium | 3151815 |
Stable Dosage Form Articles for Oral Administration | Gelatin Capsule with Fill Formulation | Netherlands | 3151815 |
Stable Dosage Form Articles for Oral Administration | Gelatin Capsule with Fill Formulation | Spain | 3151815 |
Stable Dosage Form Articles for Oral Administration | Gelatin Capsule with Fill Formulation | Italy | 3151815 |
Stable Dosage Form Articles for Oral Administration | Gelatin Capsule with Fill Formulation | France | 3151815 |
Stable Dosage Form Articles for Oral Administration | Gelatin Capsule with Fill Formulation | United Kingdom | 3151815 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Germany | 60 2016 001 151.4 |
Process for the Modification of a Glycoprotein Using a Beta-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Germany | 60 2015 079 939.9 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Germany | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Germany | 2911699 |
Synthesis of 6-Azido-6-Deoxy-2-N-Acetyl-Hexosamine-Nucleoside Diphosphate | Glycan Remodeling | United States | 12281135 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | United States | 12049656 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | United States | 11299759 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | United States | 9988661 |
Enzymes for Trimming of Glycoproteins | Glycan Remodeling | United States | 10858641 |
Enzymes for Trimming of Glycoproteins | Glycan Remodeling | United States | 11713453 |
Process for the Modification of a Glycoprotein Using a Beta-(1,4)-N-Acetylgalactosaminyltransferase or a Mutant Thereof | Glycan Remodeling | United States | 11046988 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | United States | 12194107 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | United States | 9504758 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | United States | 10745488 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Austria | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Austria | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Austria | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Belgium | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Belgium | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Belgium | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Bulgaria | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Bulgaria | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Poland | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Poland | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Poland | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Portugal | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Portugal | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Portugal | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Malta | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Malta | 2911699 |
Synthesis of 6-Azido-6-Deoxy-2-N-Acetyl-Hexosamine-Nucleoside Diphosphate | Glycan Remodeling | Netherlands | 2023572 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Netherlands | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Netherlands | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Netherlands | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Norway | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Norway | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Norway | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Romania | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Romania | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Sweden | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Sweden | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Sweden | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Slovenia | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Slovenia | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Slovakia | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Slovakia | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Slovakia | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | San Marino | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | San Marino | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Turkey | TR 2018 03797 T4 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Turkey | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Turkey | TR 2018 02029 T4 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Switzerland | 3134520 |
Enzymes for Trimming of Glycoproteins | Glycan Remodeling | Switzerland | 3414328 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Switzerland | 3354726 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Switzerland | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Switzerland | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | China | ZL 201680036546.X |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | China | ZL 2013800676713 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Spain | 3134520 |
Enzymes for Trimming of Glycoproteins | Glycan Remodeling | Spain | 3414328 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Spain | 3354726 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Spain | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Spain | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Hungary | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Hungary | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Hungary | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Ireland | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Ireland | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Ireland | 2911699 |
Synthesis of 6-Azido-6-Deoxy-2-N-Acetyl-Hexosamine-Nucleoside Diphosphate | Glycan Remodeling | India | 559166 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | India | 400167 |
Process for the Modification of a Glycoprotein Using a Beta-(1,4)-N-Acetylgalactosaminyltransferase or a Mutant Thereof | Glycan Remodeling | India | 447006 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | India | 425730 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Iceland | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Iceland | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Italy | 502018000006622 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Italy | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Italy | 502018000005243 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Japan | 6966162 |
Process for the Modification of a Glycoprotein Using a Beta-(1,4)-N-Acetylgalactosaminyltransferase or a Mutant Thereof | Glycan Remodeling | Japan | 7297820 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Japan | 7167071 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Japan | 6855661 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Finland | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Finland | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Finland | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | France | 3134520 |
Process for the Modification of a Glycoprotein Using a Beta-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | France | 3177633 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | France | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | France | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | United Kingdom | 3134520 |
Enzymes for Trimming of Glycoproteins | Glycan Remodeling | United Kingdom | 3414328 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | United Kingdom | 3354726 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | United Kingdom | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | United Kingdom | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Greece | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Greece | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Greece | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Croatia | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Croatia | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Croatia | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Cyprus | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Cyprus | CY1120041 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Czech Republic | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Czech Republic | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Czech Republic | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | Denmark | 3134520 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Denmark | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Denmark | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Estonia | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Estonia | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Monaco | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Monaco | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Lithuania | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Lithuania | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Luxembourg | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Luxembourg | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Latvia | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Latvia | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Serbia | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Serbia | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Albania | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | Albania | 2911699 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | North Macedonia | 3912642 |
Modified Antibody, Antibody-Conjugate and Process for the Preparation Thereof | Glycan Remodeling | North Macedonia | 2911699 |
Process for the Modification of a Glycoprotein using a Glycosyltransferase that is or is Derived from a BETA-(1,4)-N-Acetylgalactosaminyltransferase | Glycan Remodeling | UPC Agreement | 3354726 |
Enzymes for Trimming of Glycoproteins | Glycan Remodeling | UPC Agreement | 3414328 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Granulated Carnitine and Manufacturing Process | Germany | 602006029269.4 |
Methods for the Production of L-Carnitine | Granulated Carnitine and Manufacturing Process | Germany | 2501673 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Granulated Carnitine and Manufacturing Process | United States | 9084431 |
Methods for the Production of L-Carnitine | Granulated Carnitine and Manufacturing Process | United States | 8604237 |
Improved Collagen Dispersion and Method of Producing Same | Granulated Carnitine and Manufacturing Process | United States | 8748499 |
Improved Collagen Dispersion and Method of Producing Same | Granulated Carnitine and Manufacturing Process | Taiwan | I510500 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Granulated Carnitine and Manufacturing Process | China | ZL201010262857.2 |
Methods for the Production of L-Carnitine | Granulated Carnitine and Manufacturing Process | China | ZL201080051331.8 |
Methods for the Production of L-Carnitine | Granulated Carnitine and Manufacturing Process | India | 308637 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Granulated Carnitine and Manufacturing Process | Italy | 1901715 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Granulated Carnitine and Manufacturing Process | Czech Republic | 1901715 |
Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate | Granulated Carnitine and Manufacturing Process | Korea - South | 1327700 |
Methods for the Production of L-Carnitine | Granulated Carnitine and Manufacturing Process | Korea - South | 10-1823971 |
Improved Collagen Dispersion and Method of Producing Same | Granulated Carnitine and Manufacturing Process | Korea - South | 10-1611374 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | Germany | 602008022892.4 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | United States | 8241870 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | Australia | 2006249087 |
Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM® | Australia | 2006237193 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | Singapore | 182147 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | China | ZL200880018842.2 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | China | ZL200680017582.8 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | Spain | 2152728 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | Israel | 187100 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | India | 263242 |
Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM® | India | 257246 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | Japan | 5301534 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | Japan | 4991705 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | France | 2152728 |
Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence | GS GENE EXPRESSION SYSTEM® | United Kingdom | 2152728 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | Hong Kong | HK1120050 |
Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene | GS GENE EXPRESSION SYSTEM® | Hong Kong | HK1119737 |
High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell | GS GENE EXPRESSION SYSTEM® | Korea - South | 1273829 |
Transfer Station For API Seed Crystals | HPAPI Handling | United States | 11884428 |
Customizable Facility | Ibex® Solutions | United States | 11377865 |
Customizable Facility | Ibex® Solutions | United States | 10689873 |
Customizable Facility | Ibex® Solutions | United States | 11236520 |
Method And System For Providing Buffer Solutions | Ibex® Solutions | United States | 11898137 |
Method And System For Providing Buffer Solutions | Ibex® Solutions | United States | 10669518 |
Customizable Facility | Ibex® Solutions | United States | 11859403 |
Customizable Facility | Ibex® Solutions | United States | 11613900 |
Customizable Facility | Ibex® Solutions | Singapore | 11201900528P |
Customizable Facility | Ibex® Solutions | Switzerland | 3426217 |
Customizable Facility | Ibex® Solutions | Spain | 3426217 |
Customizable Facility | Ibex® Solutions | Israel | 261709 |
Method And System For Providing Buffer Solutions | Ibex® Solutions | Israel | 264373 |
Customizable Facility | Ibex® Solutions | Israel | 264374 |
Customizable Facility | Ibex® Solutions | Japan | 7009378 |
Buffer Solutions | Ibex® Solutions | Japan | 7075927 |
Customizable Facility | Ibex® Solutions | Japan | 3239085 |
Customizable Facility | Ibex® Solutions | Japan | 7526756 |
Customizable Facility | Ibex® Solutions | United Kingdom | 3426217 |
Method and System for Providing Buffer Solutions | Ibex® Solutions | Korea - South | 10-2807585 |
Customizable Facility | Ibex® Solutions | Korea - South | 10-2480770 |
Customizable Facility | Ibex® Solutions | UPC Agreement | 3426217 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | Germany | 2678037 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | United States | 10294270 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | United States | 10214560 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | Netherlands | 2678037 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | Switzerland | 2678037 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | China | ZL201510163661.0 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | China | ZL201280010479.6 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | Spain | 2678037 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | Italy | 2678037 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | Japan | 5559439 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | Japan | 6169520 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | France | 2678037 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | United Kingdom | 2678037 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | Hong Kong | HK1186668 |
Branched Linkers For Protein Drug Conjugates | Linkers for ADCs | Hong Kong | HK1213773 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | Germany | 3134128 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | United States | 11850286 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | United States | 10792369 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | United States | 9636421 |
Bioconjugates Containing Sulfamide Linkers for Use in Treatment | Linker Technology | United States | 11951175 |
Sulfamide Linkers for Use in Bioconjugates | Linker Technology | United States | 11957763 |
Improved Sulfamide Linkers for Use in Bioconjugates | Linker Technology | United States | 10874746 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | Netherlands | 3134128 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | Switzerland | 3134128 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | China | 2015800661806 |
Bioconjugates Containing Sulfamide Linkers for Use in Treatment | Linker Technology | China | ZL 201780020351.0 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | Spain | 3134128 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | India | 425726 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | Italy | 502019000063273 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | Japan | 6733993 |
Bioconjugates Containing Sulfamide Linkers for Use in Treatment | Linker Technology | Japan | 7488003 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | France | 3134128 |
Sulfamide Linker, Conjugates Thereof, and Methods of Preparation | Linker Technology | United Kingdom | 3134128 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Germany | 3540040 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Germany | 602010064092.2. |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Germany | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Germany | 2711426 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | Germany | 2864489 |
Mammalian Expression System | Mammalian Biopharmaceutical Services | Germany | 3341484 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Germany | 3645720 |
Crispr-Associated (Cas) Proteins with Reduced Immunogenicity | Mammalian Biopharmaceutical Services | Germany | 3374501 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | Germany | 3752592 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Germany | 3452608 |
Dielectric Spectroscopy Methods and Apparatus | Mammalian Biopharmaceutical Services | Germany | 602013079447.2 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Germany | 3741853 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | Germany | 3535508 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | United States | D664262 |
Method, Computing Routine, Device For Predicting Properties Of Mhc/Peptide Complexes, And Data And Peptides Produced Therefrom | Mammalian Biopharmaceutical Services | United States | 7702465 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United States | 10883076 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United States | 10179898 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United States | 9783771 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United States | 9670446 |
Dielectric Spectroscopy Methods and Apparatus | Mammalian Biopharmaceutical Services | United States | 9568449 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | United States | 9777290 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | United States | 10294491 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | United States | 11326185 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | United States | 10280436 |
Wireless Sensor Information Monitoring | Mammalian Biopharmaceutical Services | United States | 10244406 |
Wireless Sensor Information Monitoring | Mammalian Biopharmaceutical Services | United States | 11006260 |
Variable Diameter Bioreactors | Mammalian Biopharmaceutical Services | United States | 10370629 |
Variable Diameter Bioreactors | Mammalian Biopharmaceutical Services | United States | 11597900 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | United States | 11993802 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | United States | 10975409 |
Inhibition Of Protein Degradation For Improved Production | Mammalian Biopharmaceutical Services | United States | 11320422 |
Crispr-Associated (Cas) Proteins with Reduced Immunogenicity | Mammalian Biopharmaceutical Services | United States | 11566052 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | United States | 10570363 |
Mammalian Expression System | Mammalian Biopharmaceutical Services | United States | 11767537 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | United States | 11965152 |
Continuous Blade Impeller | Mammalian Biopharmaceutical Services | United States | 11739289 |
A Process For Creating Reference Data For Predicting Concentrations Of Quality Attributes | Mammalian Biopharmaceutical Services | United States | 11568955 |
Midscale Model For Organic Growth And Phasing | Mammalian Biopharmaceutical Services | United States | 12071607 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | United States | 12077786 |
Process And System For Propagating Cell Cultures While Preventing Lactate Accumulation | Mammalian Biopharmaceutical Services | United States | 11634680 |
Measuring, Monitoring And Control Of Bioprocesses Using Spectroscopy Technologies And Multivariate Data Analysis | Mammalian Biopharmaceutical Services | United States | 11609120 |
Universal Self-Regulating Mammalian Cell Line Platform For The Production Of Biologics | Mammalian Biopharmaceutical Services | United States | 12054733 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | United States | 11519515 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | United States | 10436338 |
A Method For The Reduction Of Viral Titer In Pharmaceuticals | Mammalian Biopharmaceutical Services | United States | 11034721 |
Reactor Surface Finish Effect On Cleanability | Mammalian Biopharmaceutical Services | United States | 10808216 |
Single Use Bioreactor | Mammalian Biopharmaceutical Services | United States | 10801003 |
Single Use Bioreactor | Mammalian Biopharmaceutical Services | United States | 11371002 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | United States | 11434474 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | United States | 10655111 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | United States | 11353468 |
Automated Control of Cell Culture Using Raman Spectroscopy | Mammalian Biopharmaceutical Services | United States | 12352625 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | United States | 12203948 |
Sensor Shield | Mammalian Biopharmaceutical Services | United States | 12092483 |
Process And System For Propagating Cell Cultures While Preventing Lactate Accumulation | Mammalian Biopharmaceutical Services | United States | 11999939 |
Variable Diameter Bioreactors | Mammalian Biopharmaceutical Services | United States | 12227723 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Austria | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Austria | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Australia | 2013320157 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | Australia | 2017277761 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | Australia | 2016338676 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Australia | 2017259010 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Belgium | 3540040 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Belgium | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Belgium | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Poland | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Poland | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Mexico | 371007 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Mexico | 408391 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Netherlands | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Netherlands | 2711426 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | Netherlands | 3752592 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | Netherlands | 3535508 |
Crispr-Associated (Cas) Proteins with Reduced Immunogenicity | Mammalian Biopharmaceutical Services | Netherlands | 3374501 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Norway | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Norway | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Sweden | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Sweden | 2711426 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | Sweden | 3752592 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Singapore | 11201502243Y |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | Singapore | 11201810975U |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | Singapore | 11201803017Q |
Midscale Model For Organic Growth And Phasing | Mammalian Biopharmaceutical Services | Singapore | 11202011084Y |
Single Use Bioreactor | Mammalian Biopharmaceutical Services | Singapore | 11201810780X |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Singapore | 11201809626P |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | Singapore | 11201808992U |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Taiwan | I507526 |
Variable Diameter Bioreactors | Mammalian Biopharmaceutical Services | Taiwan | I808057 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Brazil | BR1120150056040 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Brazil | BR1120180724343 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Canada | 2880750 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Canada | 3023038 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Switzerland | 2393912 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Switzerland | 3540040 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Switzerland | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Switzerland | 2711426 |
Mammalian Expression System | Mammalian Biopharmaceutical Services | Switzerland | 3341484 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Switzerland | 3645720 |
Crispr-Associated (Cas) Proteins with Reduced Immunogenicity | Mammalian Biopharmaceutical Services | Switzerland | 3374501 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | Switzerland | 3752592 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Switzerland | 3452608 |
Dielectric Spectroscopy Methods and Apparatus | Mammalian Biopharmaceutical Services | Switzerland | 2800966 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Switzerland | 3741853 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | Switzerland | 3535508 |
Sterile Disconnect for Bioprocess Systems and Method for Using Same | Mammalian Biopharmaceutical Services | Switzerland | 4244330 |
Sensor Shield | Mammalian Biopharmaceutical Services | Switzerland | 4028727 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | Switzerland | 3683579 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | China | ZL201380049575.6 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | China | ZL201380032837.8 |
Multi-Site SSI Cells For Difficult To Express Proteins | Mammalian Biopharmaceutical Services | China | 111372946 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | China | ZL202080007397.0 |
Methods For Improving Production Of Biological Products By Reducing The Level Of Endogenous Protein | Mammalian Biopharmaceutical Services | China | ZL201980046173.8 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | China | ZL201980011543.4 |
Universal Self-Regulating Mammalian Cell Line Platform For The Production Of Biologics | Mammalian Biopharmaceutical Services | China | ZL201880040140.8 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | China | ZL201780083077.1 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Spain | 3540040 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Spain | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Spain | 2711426 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | Spain | 2864489 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Spain | 3645720 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | Spain | 3752592 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Spain | 3452608 |
Dielectric Spectroscopy Methods and Apparatus | Mammalian Biopharmaceutical Services | Spain | 2800966 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Spain | 3741853 |
Sterile Disconnect for Bioprocess Systems and Method for Using Same | Mammalian Biopharmaceutical Services | Spain | 4244330 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | Spain | 3683579 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Hungary | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Hungary | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Ireland | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Ireland | 2711426 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | Ireland | 2864489 |
Dielectric Spectroscopy Methods and Apparatus | Mammalian Biopharmaceutical Services | Ireland | 2800966 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | Ireland | 3683579 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Israel | 237171 |
Methods And Compositions For Producing Therapeutic Product Variants | Mammalian Biopharmaceutical Services | Israel | 268602 |
Variable Diameter Bioreactors | Mammalian Biopharmaceutical Services | Israel | 263117 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | Israel | 263342 |
Inhibition Of Protein Degradation For Improved Production | Mammalian Biopharmaceutical Services | Israel | 260369 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | Israel | 258633 |
Continuous Blade Impeller | Mammalian Biopharmaceutical Services | Israel | 287170 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | Israel | 284460 |
Process And System For Propagating Cell Cultures While Preventing Lactate Accumulation | Mammalian Biopharmaceutical Services | Israel | 274776 |
Measuring, Monitoring And Control Of Bioprocesses Using Spectroscopy Technologies And Multivariate Data Analysis | Mammalian Biopharmaceutical Services | Israel | 273549 |
Universal Self-Regulating Mammalian Cell Line Platform For The Production Of Biologics | Mammalian Biopharmaceutical Services | Israel | 270467 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Israel | 262646 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Israel | 294241 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | Israel | 290358 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | India | 333092 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | India | 448340 |
Inhibition Of Protein Degradation For Improved Production | Mammalian Biopharmaceutical Services | India | 503602 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | India | 475346 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | India | 541442 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | India | 483854 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Italy | 3540040 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Italy | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Italy | 2711426 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | Italy | 2864489 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Italy | 3645720 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | Italy | 3752592 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Italy | 3452608 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Italy | 3741853 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | Japan | 1431555 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | Japan | 6121374 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Japan | 6162246 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | Japan | 6053923 |
Multi-Site SSI Cells For Difficult To Express Proteins | Mammalian Biopharmaceutical Services | Japan | 7467119 |
Methods And Compositions For Producing Therapeutic Product Variants | Mammalian Biopharmaceutical Services | Japan | 7252896 |
Variable Diameter Bioreactors | Mammalian Biopharmaceutical Services | Japan | 7364334 |
Inhibition Of Protein Degradation For Improved Production | Mammalian Biopharmaceutical Services | Japan | 7049253 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | Japan | 7097298 |
Continuous Blade Impeller | Mammalian Biopharmaceutical Services | Japan | 7635148 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | Japan | 7538133 |
SSI Cells With Predictable And Stable Transgene Expression And Methods Of Formation | Mammalian Biopharmaceutical Services | Japan | 7549582 |
Methods For Improving Production Of Biological Products By Reducing The Level Of Endogenous Protein | Mammalian Biopharmaceutical Services | Japan | 7543246 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Japan | 7108036 |
Process And System For Propagating Cell Cultures While Preventing Lactate Accumulation | Mammalian Biopharmaceutical Services | Japan | 7391840 |
Automated Control of Cell Culture Using Raman Spectroscopy | Mammalian Biopharmaceutical Services | Japan | 7323512 |
Single Use Bioreactor | Mammalian Biopharmaceutical Services | Japan | 6942736 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Japan | 6959942 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | Japan | 7565147 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | Japan | 7584206 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | Japan | 7404453 |
Methods Of Cell Selection | Mammalian Biopharmaceutical Services | Japan | 7678805 |
Process And System For Propagating Cell Cultures While Preventing Lactate Accumulation | Mammalian Biopharmaceutical Services | Japan | 7566995 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Finland | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Finland | 2711426 |
Bioreactor For The Cultivation of Mammalian Cells | Mammalian Biopharmaceutical Services | France | 3540040 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | France | 2393912 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | France | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | France | 2711426 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | France | 2864489 |
Mammalian Expression System | Mammalian Biopharmaceutical Services | France | 3341484 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | France | 3645720 |
Crispr-Associated (Cas) Proteins with Reduced Immunogenicity | Mammalian Biopharmaceutical Services | France | 3374501 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | France | 3752592 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | France | 3452608 |
Dielectric Spectroscopy Methods and Apparatus | Mammalian Biopharmaceutical Services | France | 2800966 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | France | 3741853 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | France | 3535508 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United Kingdom | 3540040 |
Bioreactor For The Cultivation Of Mammalian Cells | Mammalian Biopharmaceutical Services | United Kingdom | 2393912 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | United Kingdom | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | United Kingdom | 2711426 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | United Kingdom | 2864489 |
Mammalian Expression System | Mammalian Biopharmaceutical Services | United Kingdom | 3341484 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | United Kingdom | 3645720 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | United Kingdom | 3752592 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | United Kingdom | 3452608 |
Dielectric Spectroscopy Methods and Apparatus | Mammalian Biopharmaceutical Services | United Kingdom | 2800966 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | United Kingdom | 9001268353-0002 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | United Kingdom | 9001268353-0001 |
Methods Of Cell Selection And Modifying Cell Metabolism | Mammalian Biopharmaceutical Services | United Kingdom | 3741853 |
Rupture Disks For Bioreactors And Methods Of Using Same | Mammalian Biopharmaceutical Services | United Kingdom | 3535508 |
Crispr-Associated (Cas) Proteins with Reduced Immunogenicity | Mammalian Biopharmaceutical Services | United Kingdom | 3374501 |
Sterile Disconnect for Bioprocess Systems and Method for Using Same | Mammalian Biopharmaceutical Services | United Kingdom | 4244330 |
Sensor Shield | Mammalian Biopharmaceutical Services | United Kingdom | 4028727 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | United Kingdom | 3683579 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Hong Kong | HK1206061 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | Hong Kong | HK1202580 |
Multi-Site SSI Cells For Difficult To Express Proteins | Mammalian Biopharmaceutical Services | Hong Kong | HK40032919 |
Crispr-Associated (Cas) Proteins with Reduced Immunogenicity | Mammalian Biopharmaceutical Services | Hong Kong | HK1253323 |
Buffer Formulation Method And System | Mammalian Biopharmaceutical Services | Hong Kong | HK40047974 |
Methods For Improving Production Of Biological Products By Reducing The Level Of Endogenous Protein | Mammalian Biopharmaceutical Services | Hong Kong | 40047568 |
Universal Self-Regulating Mammalian Cell Line Platform For The Production Of Biologics | Mammalian Biopharmaceutical Services | Hong Kong | 40019706B |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Czech Republic | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Czech Republic | 2711426 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Denmark | 2898077 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Denmark | 2711426 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | EUIPO | 9001238208-0002 |
Impeller Arrangement for Fermenter | Mammalian Biopharmaceutical Services | EUIPO | 9001238208-0001 |
Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences | Mammalian Biopharmaceutical Services | Korea - South | 10-1757083 |
Site-Specific Integration | Mammalian Biopharmaceutical Services | Korea - South | 10-1761709 |
Multi-Site SSI Cells For Difficult To Express Proteins | Mammalian Biopharmaceutical Services | Korea - South | 10-2630357 |
Methods And Compositions For Producing Therapeutic Product Variants | Mammalian Biopharmaceutical Services | Korea - South | 10-2701102 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | Korea - South | 10-2451374 |
Inhibition Of Protein Degradation For Improved Production | Mammalian Biopharmaceutical Services | Korea - South | 10-2789754 |
System And Method For Regulating Cell Culture Based Production Of Biologics | Mammalian Biopharmaceutical Services | Korea - South | 10-2703858 |
Process And System For Propagating Cell Cultures While Preventing Lactate Accumulation | Mammalian Biopharmaceutical Services | Korea - South | 10-2589415 |
Universal Self-Regulating Mammalian Cell Line Platform For The Production Of Biologics | Mammalian Biopharmaceutical Services | Korea - South | 10-2647165 |
Reactor Surface Finish Effect On Cleanability | Mammalian Biopharmaceutical Services | Korea - South | 10-2638347 |
Single Use Bioreactor | Mammalian Biopharmaceutical Services | Korea - South | 10-2398310 |
Modulation Of Lipid Metabolism For Protein Production | Mammalian Biopharmaceutical Services | Korea - South | 10-2536221 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | Korea - South | 10-2408260 |
Variable Diameter Bioreactors | Mammalian Biopharmaceutical Services | Korea - South | 10-2681292 |
Method For Stabilizing Proteins | Mammalian Biopharmaceutical Services | Korea - South | 10-2499718 |
Sterile Disconnect for Bioprocess Systems and Method for Using Same | Mammalian Biopharmaceutical Services | UPC Agreement | 4244330 |
Sensor Shield | Mammalian Biopharmaceutical Services | UPC Agreement | 4028727 |
Compositions And Methods For The Detection Of Host Cell Proteins | Mammalian Biopharmaceutical Services | UPC Agreement | 3683579 |
Lipid Multiparticulate Formulations | Multiparticulate Composition | United States | 11324699 |
Gelling Multiparticulates | Multiparticulate Composition | United States | 11510877 |
Gelling Multiparticulates | Multiparticulate Composition | United States | 12036322 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | Germany | 602007041896.8 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | Germany | 602014004180.9 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | United States | 11116728 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | United States | 10357462 |
Multiparticulate Compositions With Improved Stability | Multiparticulates | United States | 7736672 |
Extrusion Process For Forming Chemically Stable Drug Multiparticulates | Multiparticulates | United States | 7625507 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | United States | 10835451 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | Belgium | 2949309 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | Spain | 2949309 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | Italy | 2949309 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | France | 2091519 |
Apparatus and Process for Filling Particular Materials | Multiparticulates | France | 2949309 |
Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core | Multiparticulates | United Kingdom | 2091519 |
Apparatus And Process For Filling Particular Materials | Multiparticulates | United Kingdom | 2949309 |
Mycopolasma Detecting Methods and Materials | MYCOALERT® Mycoplasma Detection Kit | United States | 7585644 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Germany | 2208780 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Germany | 2208779 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Germany | 1961807 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Germany | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Germany | 502010016602.5 |
Device and Method for Large Volume Transfection | Nucleofector® System | Germany | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Germany | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | Germany | 3260163 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Germany | 3750983 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | United States | 9080139 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | United States | 8450102 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | United States | 7700357 |
Method and Circuit Arrangement for Treating Biomaterial | Nucleofector® System | United States | 7732175 |
Container and Device for Generating Electric Fields in Different Chambers | Nucleofector® System | United States | 8101401 |
Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produced by this Method | Nucleofector® System | United States | 8895152 |
Device and Method for Processing Biological Material | Nucleofector® System | United States | 7704727 |
Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current | Nucleofector® System | United States | 8173416 |
Container with at Least One Electrodenucleofector Solutions | Nucleofector® System | United States | 7678564 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | United States | 9624486 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | United States | 11021698 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | United States | 9701954 |
Method and Device for the Electrical Treatment of Reaction Spaces | Nucleofector® System | United States | 9249384 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | United States | 9284525 |
Device and Method for Large Volume Transfection | Nucleofector® System | United States | 11661595 |
Device and Method for Large Volume Transfection | Nucleofector® System | United States | 11352615 |
Device and Method for Large Volume Transfection | Nucleofector® System | United States | 10633646 |
Device and Method for Large Volume Transfection | Nucleofector® System | United States | 10336996 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Austria | 2208780 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Austria | 2208779 |
Device and Method for Large Volume Transfection | Nucleofector® System | Austria | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Austria | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Austria | 3750983 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Australia | 2006268953 |
Device and Method for Large Volume Transfection | Nucleofector® System | Australia | 2015254739 |
Device and Method for Large Volume Transfection | Nucleofector® System | Australia | 2015254741 |
Device and Method for Large Volume Transfection | Nucleofector® System | Australia | 2018205130 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Belgium | 2208780 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Belgium | 2208779 |
Device and Method for Large Volume Transfection | Nucleofector® System | Belgium | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Belgium | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Belgium | 3750983 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Netherlands | 2208779 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Netherlands | 1961807 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Netherlands | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Netherlands | 2399984 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Netherlands | 2208780 |
Device and Method for Large Volume Transfection | Nucleofector® System | Netherlands | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Netherlands | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | Netherlands | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Netherlands | 3750983 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Norway | 2208780 |
Device and Method for Large Volume Transfection | Nucleofector® System | Norway | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Norway | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Norway | 3750983 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Sweden | 2208779 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Sweden | 1961807 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Sweden | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Sweden | 2399984 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Sweden | 2208780 |
Device and Method for Large Volume Transfection | Nucleofector® System | Sweden | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Sweden | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | Sweden | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Sweden | 3750983 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Canada | 2613984 |
Device and Method for Large Volume Transfection | Nucleofector® System | Canada | 2946666 |
Device and Method for Large Volume Transfection | Nucleofector® System | Canada | 2946472 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Switzerland | 2208780 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Switzerland | 2208779 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Switzerland | 1961807 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Switzerland | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Switzerland | 2399984 |
Device and Method for Large Volume Transfection | Nucleofector® System | Switzerland | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Switzerland | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | Switzerland | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Switzerland | 3750983 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | China | ZL200680024248.5 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | China | ZL201180030237.9 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | China | ZL201180030236.4 |
Device and Method for Large Volume Transfection | Nucleofector® System | China | ZL201580022290.2 |
Device and Method for Large Volume Transfection | Nucleofector® System | China | ZL201580022367.6 |
Device and Method for Large Volume Transfection | Nucleofector® System | China | ZL202010191131.8 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | China | ZL202080043057.3 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Spain | 2208780 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Spain | 2208779 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Spain | 1961807 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Spain | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Spain | 2399984 |
Device and Method for Large Volume Transfection | Nucleofector® System | Spain | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Spain | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | Spain | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Spain | 3750983 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Ireland | 2208780 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Ireland | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Ireland | 2399984 |
Device and Method for Large Volume Transfection | Nucleofector® System | Ireland | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Ireland | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Ireland | 3750983 |
Device and Method for Large Volume Transfection | Nucleofector® System | India | 359428 |
Device and Method for Large Volume Transfection | Nucleofector® System | India | 364412 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Italy | 2208780 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Italy | 2208779 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | Italy | 1961807 |
Device and Method for Large Volume Transfection | Nucleofector® System | Italy | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Italy | 502019000085478 |
Device and Method for Large Volume Transfection | Nucleofector® System | Italy | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Italy | 3750983 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Japan | 6013419 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Japan | 5560288 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Japan | 4982489 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Japan | 5885144 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Japan | 5840204 |
Method and Device for the Electrical Treatment of Reaction Spaces | Nucleofector® System | Japan | 5926560 |
Device and Method for Large Volume Transfection | Nucleofector® System | Japan | 6750810 |
Device and Method for Large Volume Transfection | Nucleofector® System | Japan | 6642875 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Japan | 7499278 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Finland | 2208780 |
Device and Method for Large Volume Transfection | Nucleofector® System | Finland | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Finland | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Finland | 3750983 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | France | 2208780 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | France | 2208779 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | France | 1961807 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | France | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | France | 2399984 |
Device and Method for Large Volume Transfection | Nucleofector® System | France | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | France | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | France | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | France | 3750983 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | United Kingdom | 2208780 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | United Kingdom | 2208779 |
Device and Method for Stabilising the Flow Through a Chamber | Nucleofector® System | United Kingdom | 1961807 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | United Kingdom | 2399985 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | United Kingdom | 2399984 |
Device and Method for Large Volume Transfection | Nucleofector® System | United Kingdom | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | United Kingdom | 2940120 |
Device and Method for Large Volume Transfection | Nucleofector® System | United Kingdom | 3260163 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | United Kingdom | 3750983 |
Method for Treating Small Volumes with Electrical Current | Nucleofector® System | Hong Kong | HK1122840 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Hong Kong | HK40067820 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Denmark | 2208780 |
Device and Method for Large Volume Transfection | Nucleofector® System | Denmark | 2940121 |
Device and Method for Large Volume Transfection | Nucleofector® System | Denmark | 3260163 |
Device and Method for Large Volume Transfection | Nucleofector® System | Denmark | 2940120 |
Method and Device for Controlling the Filling Level in a Chamber | Nucleofector® System | Denmark | 3750983 |
A Method and Device for the Electrial Treatment of a Plurality of Containers | Nucleofector® System | Korea - South | 1686260 |
Container with a Plurality of Reaction Spaces and Electrodes | Nucleofector® System | Korea - South | 1686258 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Korea - South | 10-1853514 |
Method and Electrode Assembly for Treating Adherent Cells | Nucleofector® System | Korea - South | 10-1853515 |
Device and Method for Large Volume Transfection | Nucleofector® System | Korea - South | 10-2407937 |
Device and Method for Large Volume Transfection | Nucleofector® System | Korea - South | 10-2412820 |
Device and Method for Large Volume Transfection | Nucleofector® System | Korea - South | 10-2597255 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | Germany | 602015064771.8 |
Nanoparticles Comprising Drug, A Non-Ionizable Cellulosic Polymer And Tocopheryl Polyethylene Glocol Succinate | Other Solubilization | United States | 9545384 |
REISSUE-Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials | Other Solubilization | United States | RE47033 |
Pharmaceutical Compositions Of Semi-Ordered Drugs And Polymers | Other Solubilization | United States | 8257739 |
Methods And Compositions For Maintaining Active Agents In Intra-Articular Spaces | Other Solubilization | United States | 9084727 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | United States | 11364203 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | Belgium | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | Portugal | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | Switzerland | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | Ireland | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | Japan | 6650933 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | France | 3212169 |
Process For Forming Active Domains Dispersed In A Matrix | Other Solubilization | United Kingdom | 3212169 |
Single-Use Spray Drying Components And Methods Of Using The Same | Particle Engineering - Alt Spray Dryers | Germany | 3676548 |
Single-Use Spray Drying Components And Methods Of Using The Same | Particle Engineering - Alt Spray Dryers | United States | 11619445 |
Single-Use Spray Drying Components And Methods Of Using The Same | Particle Engineering - Alt Spray Dryers | United States | 12072146 |
Single-Use Spray Drying Components And Methods Of Using The Same | Particle Engineering - Alt Spray Dryers | Japan | 7184877 |
Single-Use Spray Drying Components And Methods Of Using The Same | Particle Engineering - Alt Spray Dryers | France | 3676548 |
Single-Use Spray Drying Components And Methods Of Using The Same | Particle Engineering - Alt Spray Dryers | United Kingdom | 3676548 |
Flash Nozzle Assembly | Particle Engineering - Hot Process | United States | 11925954 |
Flash Nozzle Assembly | Particle Engineering - Hot Process | Switzerland | 4055337 |
Flash Nozzle Assembly | Particle Engineering - Hot Process | China | ZL2020800755147 |
Flash Nozzle Assembly | Particle Engineering - Hot Process | Spain | 4055337 |
Flash Nozzle Assembly | Particle Engineering - Hot Process | Japan | 7628538 |
Flash Nozzle Assembly | Particle Engineering - Hot Process | United Kingdom | 4055337 |
Flash Nozzle Assembly | Particle Engineering - Hot Process | UPC Agreement | 4055337 |
Spray Drying Process For Low Aspect Ratio Particles Comprising Poly[(Methyl Methacrylate)-Co-(Methalcrylic Acid)] | Particle Engineering - Particle Characteristics | United States | 11708463 |
Spray Drying Process For Low Aspect Ratio Particles Comprising Poly[(Methyl Methacrylate)-Co-(Methacrylic Acid)] | Particle Engineering - Particle Characteristics | Canada | 3094591 |
Spray Drying Process For Low Aspect Ratio Particles Comprising Poly[(Methyl Methacrylate)-Co-(Methacrylic Acid)] | Particle Engineering - Particle Characteristics | Switzerland | 3773509 |
Spray Drying Process For Low Aspect Ratio Particles Comprising Poly[(Methyl Methacrylate)-Co-(Methacrylic Acid)] | Particle Engineering - Particle Characteristics | China | ZL201980024614.4 |
Spray Drying Process For Low Aspect Ratio Particles Comprising Poly[(Methyl Methacrylate)-Co-(Methacrylic Acid)] | Particle Engineering - Particle Characteristics | Spain | 3773509 |
Spray Drying Process For Low Aspect Ratio Particles Comprising Poly[(Methyl Methacrylate)-Co-(Methacrylic Acid)] | Particle Engineering - Particle Characteristics | Ireland | 3773509 |
Spray Drying Process For Low Aspect Ratio Particles Comprising Poly[(Methyl Methacrylate)-Co-(Methacrylic Acid)] | Particle Engineering - Particle Characteristics | Japan | 7244536 |
Spray Drying Process For Low Aspect Ratio Particles Comprising Poly[(Methyl Methacrylate)-Co-(Methacrylic Acid)] | Particle Engineering - Particle Characteristics | United Kingdom | 3773509 |
Spray Drying Process For Low Aspect Ratio Particles Comprising Poly[(Methyl Methacrylate)-Co-(Methacrylic Acid)] | Particle Engineering - Particle Characteristics | UPC Agreement | 3773509 |
Ammonia As A Processing Aid For Sprayed Solid Dispersions | Particle Engineering - Processing Aids | Switzerland | 4013393 |
Acetic Acid As Processing Aid In Spray Drying For Basic Drugs | Particle Engineering - Processing Aids | Switzerland | 4221692 |
Ammonia As A Processing Aid For Sprayed Solid Dispersions | Particle Engineering - Processing Aids | Spain | 4013393 |
Acetic Acid As Processing Aid In Spray Drying For Basic Drugs | Particle Engineering - Processing Aids | Spain | 4221692 |
Ammonia As A Processing Aid For Sprayed Solid Dispersions | Particle Engineering - Processing Aids | Ireland | 4013393 |
Acetic Acid As Processing Aid In Spray Drying For Basic Drugs | Particle Engineering - Processing Aids | Ireland | 4221692 |
Ammonia As A Processing Aid For Sprayed Solid Dispersions | Particle Engineering - Processing Aids | Japan | 7590409 |
Ammonia As A Processing Aid For Sprayed Solid Dispersions | Particle Engineering - Processing Aids | United Kingdom | 4013393 |
Acetic Acid As Processing Aid In Spray Drying For Basic Drugs | Particle Engineering - Processing Aids | United Kingdom | 4221692 |
Ammonia As A Processing Aid For Sprayed Solid Dispersions | Particle Engineering - Processing Aids | UPC Agreement | 4013393 |
Acetic Acid As Processing Aid In Spray Drying For Basic Drugs | Particle Engineering - Processing Aids | UPC Agreement | 4221692 |
Dynamically Controlling an Automated System | PyroTec® Pro System | United States | 10928407 |
Dynamically Controlling an Automated System | PyroTec® Pro System | United States | 10768190 |
Dynamically Controlling an Automated System | PyroTec® Pro System | Mexico | 387422 |
Dynamically Controlling an Automated System | PyroTec® Pro System | Singapore | 11201906639Q |
Dynamically Controlling an Automated System | PyroTec® Pro System | China | ZL201880009012.7 |
Dynamically Controlling an Automated System | PyroTec® Pro System | Japan | 7227911 |
Dynamically Controlling an Automated System | PyroTec® Pro System | Japan | 7561897 |
Dynamically Controlling an Automated System | PyroTec® Pro System | Hong Kong | HK40017147 |
Dynamically Controlling an Automated System | PyroTec® Pro System | Korea - South | 10-2507099 |
Dynamically Controlling an Automated System | PyroTec® Pro System | Korea - South | 10-2634499 |
Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powde | Small Molecules - Micronization | Germany | 2838661 |
Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | Germany | 2806856 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | Germany | 3519100 |
Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powde | Small Molecules - Micronization | United States | 9427743 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | United States | 11260396 |
Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powde | Small Molecules - Micronization | Switzerland | 2838661 |
Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | Switzerland | 2806856 |
Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General, With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised, And Corresponding Process For Micronisation Of A Powde | Small Molecules - Micronization | Italy | 1411465 |
Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | Italy | 1409966 |
Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills | Small Molecules - Micronization | Japan | 6158225 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | Japan | 7068319 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | France | 3519100 |
Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations | Small Molecules - Micronization | United Kingdom | 3519100 |
Drying Of Drug-Containing Particles | Spray Drying | Germany | 602007041938.7 |
Drying Of Drug-Containing Particles | Spray Drying | Germany | 602006047398.2 |
Spray-Drying Process | Spray Drying | Germany | 602010036172.1 |
Spray-Drying Process | Spray Drying | Germany | 602010066627.1 |
Drying Of Drug-Containing Particles | Spray Drying | United States | 8834929 |
Drying Of Drug-Containing Particles | Spray Drying | United States | 9265731 |
High-Temperature Spray Drying Process And Apparatus | Spray Drying | United States | 9248584 |
Spray-Drying Process | Spray Drying | United States | 9724664 |
Spray-Drying Process | Spray Drying | United States | 10300443 |
Spray-Drying Process | Spray Drying | United States | 10675602 |
Drying Of Drug-Containing Particles | Spray Drying | Belgium | 1855652 |
Spray-Drying Process | Spray Drying | Belgium | 3130396 |
Drying Of Drug-Containing Particles | Spray Drying | Portugal | 2043610 |
Drying Of Drug-Containing Particles | Spray Drying | Portugal | 1855652 |
Spray-Drying Process | Spray Drying | Portugal | 3130396 |
Spray-Drying Process | Spray Drying | Switzerland | 3130396 |
Spray-Drying Process | Spray Drying | Spain | 3130396 |
Drying Of Drug-Containing Particles | Spray Drying | Ireland | 2043610 |
Drying Of Drug-Containing Particles | Spray Drying | Ireland | 1855652 |
Spray-Drying Process | Spray Drying | Ireland | 3130396 |
Spray-Drying Process | Spray Drying | Italy | 3130396 |
Drying Of Drug-Containing Particles | Spray Drying | France | 2043610 |
Drying Of Drug-Containing Particles | Spray Drying | France | 1855652 |
Spray-Drying Process | Spray Drying | France | 2411137 |
Spray-Drying Process | Spray Drying | France | 3130396 |
Drying Of Drug-Containing Particles | Spray Drying | United Kingdom | 2043610 |
Drying Of Drug-Containing Particles | Spray Drying | United Kingdom | 1855652 |
Spray-Drying Process | Spray Drying | United Kingdom | 3130396 |
Spray-Drying Process | Spray Drying | United Kingdom | 2411137 |
Film, Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent | TiO2 Free Capsules | Germany | 3983477 |
Capsules With Opacifier | TiO2 Free Capsules | Germany | 3758685 |
Capsules With Opacifier | TiO2 Free Capsules | United States | 11517535 |
Film-Forming Composition Comprising Surfactant Or Surfactant And Salt As An Opacifying Agent | TiO2 Free Capsules | United States | 11801205 |
Pullulan Capsules | TiO2 Free Capsules | United States | 11576870 |
Film-Forming Composition Comprising Surfactant Or Surfactant And Salt As An Opacifying Agent | TiO2 Free Capsules | United States | 12303575 |
Capsules With Opacifier | TiO2 Free Capsules | United States | 11890383 |
Pullulan Capsules | TiO2 Free Capsules | United States | 11878079 |
Film, Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent | TiO2 Free Capsules | Belgium | 3983477 |
Capsules With Opacifier | TiO2 Free Capsules | Belgium | 3758685 |
Film, Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent | TiO2 Free Capsules | Netherlands | 3983477 |
Capsules With Opacifier | TiO2 Free Capsules | Netherlands | 3758685 |
Capsules With Opacifier | TiO2 Free Capsules | Canada | 3100248 |
Film, Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent | TiO2 Free Capsules | Switzerland | 3983477 |
Capsules With Opacifier | TiO2 Free Capsules | Switzerland | 3758685 |
Pullulan Capsules | TiO2 Free Capsules | Switzerland | 3609476 |
Film-Forming Composition Comprising Surfactant Or Surfactant And Salt As An Opacifying Agent | TiO2 Free Capsules | China | ZL201980045102.6 |
Capsules With Opacifier | TiO2 Free Capsules | China | ZL201980032910.9 |
Film, Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent | TiO2 Free Capsules | Spain | 3983477 |
Capsules With Opacifier | TiO2 Free Capsules | Spain | 3758685 |
Pullulan Capsules | TiO2 Free Capsules | Spain | 3609476 |
Gelatin Capsules With Ground Calcium Carbonate | TiO2 Free Capsules | India | 556604 |
Film, Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent | TiO2 Free Capsules | Italy | 3983477 |
Capsules With Opacifier | TiO2 Free Capsules | Italy | 3758685 |
Film-Forming Composition Comprising Surfactant Or Surfactant And Salt As An Opacifying Agent | TiO2 Free Capsules | Japan | 6887456 |
Capsules With Opacifier | TiO2 Free Capsules | Japan | 7368383 |
Gelatin Capsules With Ground Calcium Carbonate | TiO2 Free Capsules | Japan | 7653980 |
Capsules With Opacifier | TiO2 Free Capsules | Japan | 7681077 |
Film, Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent | TiO2 Free Capsules | France | 3983477 |
Capsules With Opacifier | TiO2 Free Capsules | France | 3758685 |
Film, Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent | TiO2 Free Capsules | United Kingdom | 3983477 |
Capsules With Opacifier | TiO2 Free Capsules | United Kingdom | 3758685 |
Pullulan Capsules | TiO2 Free Capsules | United Kingdom | 3609476 |
Film-Forming Composition Comprising Surfactant Or Surfactant And Salt As An Opacifying Agent | TiO2 Free Capsules | Hong Kong | HK40040921 |
Capsules With Opacifier | TiO2 Free Capsules | Hong Kong | HK40035647 |
Pullulan Capsules | TiO2 Free Capsules | Croatia | 3609476 |
Pullulan Capsules | TiO2 Free Capsules | UPC Agreement | 3609476 |
Method Of Manufacture And Pasteurization Of Products Containing Undenatured Collagen | UC-II® Collagen | United States | 11793217 |
Composition and Nutritional Supplement Made Therefrom | UC-II® Collagen | United Kingdom | 3655018 |
Composition and Nutritional Supplement Made Therefrom | UC-II® Collagen | UPC Agreement | 3655018 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | Undenatured Collagen Use | United States | 9066926 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | Undenatured Collagen Use | Australia | 2014202041 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | Undenatured Collagen Use | Mexico | 347669 |
Method of Reducing Exercise-Induced Joint Pain in Non-Arthritic Mammals | Undenatured Collagen Use | Malaysia | MY-180106-A |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | Undenatured Collagen Use | Philippines | 2014/50143 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | Undenatured Collagen Use | Singapore | 11201403524R |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | Undenatured Collagen Use | Canada | 2846644 |
Method of Reducing Exercise-Induced Joint Pain in Non-arthritic Mammals | Undenatured Collagen Use | Chile | 61835 |
Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals | Undenatured Collagen Use | Korea - South | 10-1664290 |
Methods and Constructs for Production of Lentiviral Vector | Viral Vector Formulations | United States | 12037599 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 60 2005 020 972.7 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 1824961 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 2591121 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 602015034267.4 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 3332005 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | Germany | 3132028 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | United States | 9279128 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | United States | 8735099 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | United States | 8962277 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | United States | 10590427 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United States | 10428123 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United States | 11168117 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United States | 9150870 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | United States | 11359223 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | United States | 10160988 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United States | 9512432 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United States | 11401523 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United States | 10301634 |
Improved Fermentation Process | XS Technologies® - Microbial Biopharmaceutical Services | United States | 11377677 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | United States | 10752907 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | United States | 10865416 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | United States | 11773424 |
Recombinant Host Cell with Altered Membrane Lipid Composition | XS Technologies® - Microbial Biopharmaceutical Services | United States | 11479798 |
Recombinant Host Cell with Altered Membrane Lipid Composition | XS Technologies® - Microbial Biopharmaceutical Services | United States | 12123044 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United States | 11976284 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Austria | E466090 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 1824961 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 965820 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 3132039 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Austria | ATE1155873 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 1231985 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 843821 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Austria | ATE1107543 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 3332005 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | Austria | 3132028 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | Australia | 2015248815 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Australia | 2015248807 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Australia | 2016303026 |
Host Cell for Producing a Protein of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Australia | 2019218931 |
Recombinant Host Cell with Altered Membrane Lipid Composition | XS Technologies® - Microbial Biopharmaceutical Services | Australia | 2018241920 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 1824980 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 1824961 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 3132039 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Belgium | 3332005 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Poland | 2591121 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Poland | 3663401 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 1824980 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 1824961 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 2591121 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 3132039 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 3332005 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | Netherlands | 3132028 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 1824980 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 2591121 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Sweden | 3332005 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 132976 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 149071 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 132972 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 10201804002P |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 11201507557U |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 11201502745X |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 10201602673P |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 11201800226X |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 11202108893S |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Singapore | 11202105667R |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Taiwan | I853878 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 2589937 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 2589823 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 2803719 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 2945877 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 2903568 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 2886460 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 2849856 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 2992170 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 2948369 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Canada | 3125217 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 1824980 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 1824961 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 2591121 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 3132039 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 3332005 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 3132028 |
Helper Factors for Expressing Proteins in Yeast | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 4127185 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Switzerland | 3584322 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL200580041794.5 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL200580041600.1 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL201180042739.3 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL201580032885.6 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL201380056279.9 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL2016800583888 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL201580032989.7 |
Means and Methods for Increased Protein Expression by Use of Transcription Factors | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL201980056449.0 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL202080008585.5 |
Host Cell for Producing a Protein of Interest | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL201980024462.8 |
Recombinant Host Cell with Altered Membrane Lipid Composition | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL201880028304.5 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | China | ZL202110953383.4 |
Rhamnose promoter expression system | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 1824980 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 1824961 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 2591121 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 2970994 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 3332005 |
Helper Factors for Expressing Proteins in Yeast | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 4127185 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Spain | 3584322 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 1824961 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 3332005 |
Helper Factors for Expressing Proteins in Yeast | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 4127185 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Ireland | 3584322 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 183608 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 183609 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 248361 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 241340 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 266700 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 238420 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 231859 |
Improved Fermentation Process | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 261411 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 257000 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | Israel | 248376 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | India | 400397 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | India | 414860 |
Improved Fermentation Process | XS Technologies® - Microbial Biopharmaceutical Services | India | 385062 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 1824980 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 1824961 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 2591121 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 2912053 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 3130598 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Italy | 3332005 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 5069124 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 5080269 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 5997140 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 6982607 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 6698352 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 6556625 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 6113736 |
Improved Fermentation Process | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 6974341 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 6833812 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 7062633 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 7566762 |
Means and Methods for Increased Protein Expression by Use of Transcription Factors | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 7645076 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 7061234 |
Recombinant Host Cell with Altered Membrane Lipid Composition | XS Technologies® - Microbial Biopharmaceutical Services | Japan | 7189145 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | France | 1824980 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | France | 1824961 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | France | 2591121 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | France | 3132039 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | France | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | France | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | France | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | France | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | France | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | France | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | France | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | France | 3332005 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | France | 3132028 |
Rhamnose promoter expression system | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 1824980 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 1824961 |
Production Cell Line | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 2591121 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 3132039 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 3130598 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 3332005 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 3132028 |
Helper Factors for Expressing Proteins in Yeast | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 4127185 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | United Kingdom | 3584322 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Hong Kong | HK1115156 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Hong Kong | HK1115155 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Hong Kong | HK1208037 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Hong Kong | HK1251256 |
Host Cell for Producing a Protein of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Hong Kong | HK40033661 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Hong Kong | HK40063356 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Hong Kong | HK40054115 |
Rhamnose Promoter Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Denmark | 1824980 |
Melibiose Operon Expression System | XS Technologies® - Microbial Biopharmaceutical Services | Denmark | 1824961 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Denmark | 2970994 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Denmark | 2912053 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Denmark | 2764016 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Denmark | 3663401 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Denmark | 3874047 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Denmark | 3508494 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Denmark | 3332005 |
Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography | XS Technologies® - Microbial Biopharmaceutical Services | Lithuania | 3663401 |
Recombinant Host Cell for Expressing Proteins of Interest | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2291978 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2128959 |
Expression Sequences | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2079293 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-1954389 |
Regulatable Promoter | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2128957 |
Improved Fermentation Process | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2593407 |
Promoter Variants | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2253479 |
Recombinant Host Cell Engineered to Overexpress Helper Proteins | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2373954 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2495283 |
Recombinant Host Cell with Altered Membrane Lipid Composition | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2692583 |
Carbon-Source Regulated Protein Production in a Recombinant Host Cell | XS Technologies® - Microbial Biopharmaceutical Services | Korea - South | 10-2699074 |
Helper Factors for Expressing Proteins in Yeast | XS Technologies® - Microbial Biopharmaceutical Services | UPC Agreement | 4127185 |
Constitutive Promoter | XS Technologies® - Microbial Biopharmaceutical Services | UPC Agreement | 3584322 |